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Abstract 
Telomerase is crucial for maintaining telomere's length. However, its 
expression/activity is particularly detected in 'immortalized cells' such as cancer 
cells and embryonic stem cells (ESCs) whereas only little or none is found in somatic 
cells. Tt has been suggested that the high level of telomerase activity participates in 
maintaining the self-renewal property of ESCs by stabilizing the telomere length. 
The regulation of telomerase activity is mainly on TERT, the catalytic subunit of 
telomerase. Currently, Pin2/TRF1-interacting protein (PinXl) was found to directly 
interact with TERT and regulate telomerase's activity in other cell types. We have 
recently showed that mouse PinXl (mPinXl) is present in mESCs. In addition, 
another mPinXl transcript variant, which is predicted to encode a novel protein 
isoform (named as "mPinXlt"), was detected in mESCs at mRNA level. We firstly 
characterized mPinXl and mPinXlt in terms of their expression levels and 
sub-cellular localization in undifferentiated mESCs. By qPCR, the expression level 
of mPinXl was found to be higher in undifferentiated mESCs than their 
differentiation derivatives, while an opposite trend was detected for mPinXlt. This 
hints that mPinXl and mPinXlt may be involved in the maintenance of the 
undifferentiated state or differentiation processes of mESCs. By confocal microscopy, 
mPinXl and mPinXlt were found to mainly localize in the nucleolus in 
i 
undifferentiated mESCs. We also confirmed the interaction ofmPinXl and mPinXlt 
with mouse (m)TERT by co-immunoprecipitation. 
Transient knockdown of mPinXl slightly decreased telomerase activity, while 
over-expression slightly increased telomerase activity, suggesting that mPinXl might 
not act as a negative regulator of telomerase in mESCs as in other cell types. Both 
transient knockdown and over-expression of mPinXl caused an inhibitory effect on 
cell proliferation without affecting cell cycle distribution and pluripotency, showing 
that mPinXl might affect mESCs proliferation by other pathways. However, all the 
effects observed in transient experiments were not detected in stable over-expression 
and knockdown cell lines, probably due to some other mechanisms compensating the 
effect. When the stable cell lines were subjected to differentiation, mPinXl 
over-expressed groups caused an advanced onset of reaching the maximum 
percentage of beating EBs, while mPinXl knock-down groups caused a decreased 
percentage of beating EBs formed. Moreover, over-expression of mPinXlt led to a 
slight delay of onset of spontaneous beating in EBs. All these results hinted a 
potential role of mPinXl and mPinXlt in mESC differentiation. Besides, 
over-expression of mPinXlt caused an increase in mPinXl gene expression, 
suggesting a possible regulatory role of this splice variant on mPinXl. Further 
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Chapter / Inlroduclion 
CHAPTER ONE INTRODUCTION 
1.1 Embryonic stem cells (ESCs) 
1.1.1 What are ESCs and the characteristics of ESCs 
Embryonic stem cells (ESCs) are derived from the inner cell mass of early embryos 
called blastocyts. They were first isolated from mouse embryos in 1981 [32, 59 . 
ESCs have three distinct properties. Firstly, they are imspecialized, meaning that they 
do not have any tissue-specific structures to let them perform specialized functions. 
For example, they cannot co-ordinate with their neighboring cells to contract and 
pump blood like heart muscle cells or secrete any digestive enzymes like the 
secretory cells in the stomach. Secondly, they are pluripotent, which allows them to 
differentiate into any types of cells in the three germs layers: endoderm, mesoderm, 
and ectoderm. Thirdly, ESCs can undergo long term self-renewal. They can 
proliferate indefinitely in culture while maintaining its imspecialized and pluripotent 
properties. 
1.1.2 Promising use of ESCs in drug development and regenerative medicine 
Nowadays the high-throughput screening of drugs generally rely on the use of highly 
proliferative immortalized cell lines because they are easy to grow, have unlimited 
supply and are inexpensive. However, they may not accurately represent how the 
1 
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normal human tissues response to the drug candidates [30]. ESCs is an attractive 
candidate for drug screening as they can proliferate in an unlimited manner and be 
differentiated into nearly all specific cell types, thus supplying a large variety of cells 
for investigating tissue specific responses of the drug candidates. (Fig. 1.1) 
On the other hand, ESCs couid potentially provide an unlimited supply of different 
tissues for human transplantation [67], including those with limited regeneration 
capacity. Transplantation of derivatives from ESCs to replace or repair the cell lost 
has been proposed as future therapies for degenerative diseases, like Parkinson's 
disease, Huntington's disease, type I diabetes mellitus, and myocardial infarction [7, 
38,55]. 
Before putting ESCs into therapeutic use, some obstacles have to be overcome. A 
central challenge is our lack of full understanding of the intrinsic mechanism that 
regulates the stem cell's characteristics, and how it is regulated to become a specific 
type of cells [49]. The use of ESCs in transplantation is limited by its multilineage 
differentiaion, as the case of driving differentiation towards a single cell type using 
specific cultural conditions or growth factors is very rare [67]. In addition, there may 
be a risk of tumor formation if unwanted ESC derivatives or undifferentiated ESCs 
are transplanted into the recipient's body. Moreover, it is possible for 
immunorejection to occur, similar to the case of organ transplantation [12]. Much 
2 
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more studies and researches are needed before putting ESCs into therapeutic use. 
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Figure 1.1 Organs derived from each germ layer, adopted from 
(http://www.ncbi.nlm.nih.gov/About/primer/genetics cell.html) 
1.1.3 Maintenance of self-renewal and pluripotent properties of ESCs 
Both self-renewal and pluripotency are maintained in ESCs by the interactions of 
numerous factors, with a transcriptional network at the center [75], including Oct-4, 
Sox-2, Nanog, Tcf3 and the myc family. These key transcription factors auto- or 
cross- regulate each other so as to directly or indirectly determine the state for 
maintaining pluripotency and self-renewal by activating the associated genes and 
repressing the differentiation-promoting genes. The decrease/loss of expression of 
these factors may indicate the loss of pluripotency or differentiation. 
3 
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Typically, ESCs are cultured and maintained on a feeder layer of mouse embryonic 
fibroblasts (MEFs) in the medium containing fetal bovine serum (FBS) [70]. 
Scientists have found that conditioned media with the addition of recombinant 
leukemia inhibitory factor (LIF) protein can maintain mouse ESCs (mESCs) 
self-renewal state without the need of MEFs feeder layer [25]. It was found that LIF 
could activate the STATS pathway which is sufficient for maintaining self-renewal in 
the presence of FBS. Another extrinsic factor, bone morphogenetic protein 4 (BMP4) 
could also corporate with LIF for maintaining self-renewal in mESCs [106]. Much 
work have been done to solve the puzzle of how ESCs maintain their self-renewal 
and pluripotent characteristics, but the distinct networking pathway behind such 
renewal process needs to be unriddled. 
In this study, the role of PinXl, a telomerase regulator, in maintaining the 
characteristics of mESCs would be investigated. 
4 
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1.2 Cell cycle in ESCs 
1.2.1 Cell cycle 
The cell cycle consists of a series of events that take place in a cell leading to the 
duplication of genetic materials and replication of cells. The cell cycle consists of 
four phases. It starts with Gi phase, at which the cell increases in size and 
chromosomes prepare for replication; then it comes to the S phase where the DNA 
replication occurs; thereafter, it comes to G2 phase at which the cell will continue to 
grow; and finally it comes to the M phase where mitosis occurs. When cell division 
is finished, the cells enter G| phase again. Cells can also enter Go phase and stop 
dividing, and at which it may also start differentiation. 
To ensure the correct transmission of genetic information from generation to 
generation, cell cycle progression is controlled by mechanisms and checkpoints that 
maintain the four cell cycle phases in the correct order to ensure that DNA is 
replicated correctly and distributed equally to each daughter cell. Studies in various 
eukaryotes have demonstrated that progression through the cell cycle is driven by 
activation and inactivation of cyclin-dependent kinases (CDKs), which trigger the 
transition to subsequent phases of the cycle. CDKs are small serine/threonine protein 
kinases that require association with a cyclin subunit for their activation [90]. CDK 
levels remain constant throughout the cell cycle, while cyclins are unstable proteins 
5 
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that are synthesized and degraded at precise times during the cell cycle, thus 
generating waves of CDK activity [98]. The precise timing ofcyclin accumulation is 
a critical factor in cell cycle progression [73]. Cyclin protein levels are regulated by 
transcriptional mechanisms and at the level of protein stability. Upon cyclin binding, 
the CDK-subunit undergoes a series of conformational changes and adopts a 
catalytically active form [43]. The cell cycle progression also depends on other 
factors like growth factors, cell-cell contact, cell density and nutrient availability 
[98]. 
1.2.2 Characteristics of cell cycle of ESCs 
The special cell cycle structure that ESCs have may play an important role for 
maintaining their characteristics. ESCs cell cycle consists largely of S phase and a 
relatively short Gi phase [83]. Since differentiated cells spend the majority of their 
time in G] phase, the short Gi phase of ESCs can account for their rapid rate of cell 
proliferation, with an unusually short generation time of approximately 8-10 hours. 
Moreover, expressions of most cyclins in ESCs do not oscillate periodically; instead, 
they are present at a rather stable amount throughout the cell cycle with a 
significantly elevated level when compared to all other evaluated cell types [83]. The 
only other cases in mammalian cells in which expressions of cyclins do not oscillate 
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periodically are some tumor cell lines, which have a deregulated growth property [37, 
87]. This deregulated cyclin level, and hence the deregulated CDK activity, may 
contribute to the uncontrolled growth in these cell lines. The unusually high levels of 
CDK activity in ESCs can account for their rapid cell proliferation rate since 
suppressing CDK activity reduces ESC generation times [83]. The lack of checkpoint 
at the G| phase [11], and the absence of CDK inhibitors such as the INK family may 
also contribute to the special properties of ESCs [83] (Fig. 1.2). 
With the tight relationship between cell cycle and ESCs characteristics, knowing 
more about the mechanism controlling the cell cycle progression of ESCs may 
provide new insights into how the ESCs maintain their self-renewal and pluripotent 
properties. 
Somatic Cells ES Cells 
p53 
Checkpoint 
\ ~ Cyclin A 
Figure 1.2 Cyclin-CDK expression patterns during cell cycle progression in somatic 
cells and embryonic stem cells, adapted from Handbook of stem cells Vol: 2: 
Embryonic Stem Cells. 
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1.3 Telomere 
Telomere is the repetitive DNA sequences located at the end of linear chromosomes. 
In eukaryotes, this repetitive sequence is conserved with the G-rich sequence 
(TTAGGG)n and terminates with a 3, single-stranded overhang. The length of 
telomere is usually 10-15kb in human and 25-40kb in mice [4, 111, 112]. Telomere 
does not code for any genes but it has an important function of protecting the end of 
the chromosome together with the telomere-associated proteins. The telomere 
complex protects the DNA end from being mistaken as damaged or broken DNA and 
hence prevents the triggering of the DNA damage response pathway (DNA 
degradation and repair pathways) [14, 24, 40, 86]. Telomere is therefore very 
essential for maintaining the chromosome stability. 
1.3.1 Telomere structure and the telomeric proteins 
The telomere exists as an unusual T-loop structure in which the 3, overhang of the 
telomere invades the telomeric repeats of the duplex DNA and forms a displacement 
(D) loop. The formation of T-loop and D-loop helps to hide the 3' telomeric overhang 
into the duplex part, preventing the end of chromosome being recognized as 
damaged DNA and the activation of DNA damaged response pathway [15, 63 . 
Six telomeric proteins, namely POTl, TRFl, TRF2, RAPl, TIN2 and TPPl, have 
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been identified to be recruited in the formation ofT-loop; they were also shown to be 
crucial for maintaining the telomeric structure and in the signaling pathways 
involved in telomere ftinctions [27] (Fig. 1.3). TRFl and TRF2, each as a homodimer, 
bind to the double-stranded telomeric repeats. They also interact with many other 
proteins within the telomere signaling pathway [102]. POTl binds to the 
single-stranded telomeric repeats in the D-loop for maintaining the telomere integrity 
[102]. TIN2 and TPPl are crucial for the six telomeric proteins' assembly [66]. 
RAPl associates with TRF2 and binds to telomere. A recent study shown that a lack 
of RAP 1 increases telomere recombination and fragility [60]. Related to telomere 
ftmctioning, TRFl, TRF2, TIN2, TPPl and RAPl were shown to regulate the 
telomere length and protect the telomere [26, 27]; TRFl, TRF2, POTl and RAPl 
were found to inhibit the DNA damage response pathway [27, 60，79]; TPPl was 
shown to be involved in telomerase recruitment [88]. Besides the telomeric roles, 
RAPl has also been found to play non-telomeric roles like modulating the nuclear 
factor-KB (NF-KB)-mediated pathway [89 . 
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Figure 1.3 Telomere T-loop structure and the telomere associated proteins, adapted 
from 
(http://www.springerimages.com/Images/Biomedicine/l-10.1007 s00424-009-0728-l-H 
1.3.2 End replication problem 
During each cell division cycle, telomeres shorten due to the ‘end replication 
problem,. DNA polymerase only works from 5 ' to 3' direction with a RNA primer at 
the 5' position. On the lagging strand, after the RNA primer at the 5, end is removed 
at the end of replication, the 5' end DNA cannot be synthesized since there is no 
place beyond for the primer to anneal, thus a segment at the 5, end will be lost in 
each round of DNA replication. This process repeats in the subsequent cell divisions 
and the telomere will be shortened progressively. This recurrent loss of telomere 
eventually leads to uncapped chromosomes and triggers the DNA damage response 
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pathway [26]. 
1.3.3 Telomere dysfunction in cancer and cellular aging 
As discussed above, if the telomere becomes critically short or if there are some 
defects in the telomeric proteins, DNA damage response pathway will be triggered. 
In this case, either DNA repair, or aging, which includes the process of cellular 
senescence and/or apoptosis, will be elicited. When the cells try to repair the 
chromosome, in one case, non-homologous-end-joining pathway will be activated, 
causing chromosome end-to-end fusions; in another case, homologous recombination 
will be increased, leading to the rapid changes in telomere length and terminal 
deletions [28, 29]. However, chromosome instability will be resulted in both cases, 
leading to amplification of oncogenes and loss of tumor suppressor genes, and thus 
increasing the incidence of cancer. In another cellular aging pathway, the tumor 
suppressor p53 and/or p21 will be activated, inducing apoptosis and/or cellular 
senescence, and therefore stopping the cells to proliferate [17, 33]. 
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1.4 Telomerase 
Telomere length can be maintained by the action of an enzyme called telomerase. 
Telomerase is a ribonucleoprotein consists of the catalytic subunit, telomerase 
reverse transcriptase (TERT), and the template RNA (TR). By using the TR as 
template, TERT can add telomeric repeats onto the telomere, thereby compensating 
the loss of telomere during each cell cycle (Fig. 1.4). By the action of telomerase, the 
telomere length can be maintained. Therefore, cells with high level of telomerase 
activity may not suffer from the problem of ‘aging,. In fact, in 'immortal' cell lines 
such as cancer cells, embryonic stem cells and the adult stem cells, they have a 
detectable expression of telomerase. This telomerase activity helps maintain a stable 
telomere length even after many passages and gives the cells the ability to proliferate 
indefinitely [8, 56]. In contrast, in most somatic cells, the expression of telomerase is 
suppressed, limiting their proliferation capacity to 50-70 population doublings before 
senescence due to the critical telomere shortening [3]. Low levels of telomerase can 
also be detected in some highly proliferative tissues like human leukocytes, skin, 
mouse spleen and liver and kidney, which contain a high population of adult stem 
cells [20, 72]. 
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Figure 1.4 How telomerase adds new telomeric repeats onto the telomere, adapted 
from 
(http://www.martinfrost.ws/htmlfiles/sept2QQ8/cancer4elomerase.html) 
1.4.1 Telomerase and stem cell characteristics 
1.4.1.1 Telomerase and cell proliferation 
As mentioned in the earlier session, high telomerase expression is only restricted to 
immortal cells, such as cancer cells and stem cells, suggesting the importance of 
telomerase activity in replicative immortality. The importance of telomerase mainly 
comes from its ability to maintain telomere length in the cells under many rounds of 
cell divisions. Introduction of hTERT was done in several types of normal human 
somatic cells including retinal pigment epithelial cells, foreskin fibroblasts, large 
13 
Chapter / Inlroduclion 
vessel endothelial cells and microvascular endothelial cells [9, 39, 104]; results 
indicated that they had by-passed the replicative senescence and increased their 
maximal replication life span for more than 2 folds, in accompany with telomerase 
activity and maintained telomere length. Overexpression of hTERT also enhanced 
proliferation in hESCs and mouse skin epidermal stem cells [6, 35]. On the other 
hand, knock-down of TR of telomerase suppressed proliferation in HeLa cells [34, 
61]. In telomerease-deficient mice, proliferation was also suppressed in skin 
epidermal stem cells [35]. Telomerase activity is also associated with cell cycle 
deregulation in many cancer types [10, 46]. All these results show that telomerase 
activity is positively associated with cellular proliferation in normal somatic cells, 
stem cells and cancer cells. 
1.4.1.2 Telomerase and stem cell differentiation 
Previous studies have shown that telomerase expression and activity decreased when 
differentiation was induced in leukemia cell lines, embryonic carcinoma cell lines 
and embryonic neuronal precursor cells [2, 44, 78, 80]. This might be due to the fact 
that differentiation causes the cells to exit from the cell cycle; since telomerase 
activity is positively related to the proliferation status, differentiated cells which have 
a lower proliferative capacity would have a lower telomerase activity. On the other 
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hand, mechanisms controlling differentiation may down-regulate telomerase activity.. 
In telomerase knockout mice, the mesenchymal stem cells was found to lose the 
multipotency and the ability to differentiate into chondrocytes and adipocytes [57 . 
Overexpression of TERT was found to change the differentiation pattern of some 
stem cells. Overexpression of TERT favored differentiation towards the 
hematopoietic lineage in mouse ESCs [6], while the same inhibited neuronal 
differentiation in human NT2 neural progenitor cells [74]. In contrast, a study 
showed that ectopic expression of TERT did not affect mouse ESCs proliferation nor 
differentiation, but protected ESCs against cell death during differentiation and 
conferred ESCs resistance to apoptosis induced by stress [48]. All these studies show 
that telomerase activity has an important role in the differentiation process, however, 
the underlying mechanism of how telomerase activity affects maintenance of 
undifferentiated state or differentiation process is still yet to be established. 
1.4.2 Regulation of telomerase expression/ activity 
1.4.2.1 Regulation of telomerase at different levels 
Studies have shown that hTERT gene expression is the major determinant of 
telomerase activity hTERT transcript expression is low or even undetectable in most 
somatic cells, but it is readily detected in many of the telomerase activity positive 
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cells like cancer or stem cells [21,64,81]. The promoter region ofhTERT is inactive 
in many somatic cells, while activated in many of the telomerase positive cells [19]. 
Many of the regulators of telomerase bind to the promoter region ofhTERT, thereby 
activating or repressing the gene expression. Transcription factors c-Myc and SPl, 
steroid hormone estrogen and progesterone bind to the promoter of hTERT and 
activate its expression [45, 62, 96, 101]. On the other hand transcription factor E2F1 
and Mad, tumor suppressor p53, hormone retinoic acid suppress telomerase 
transcription [23, 69, 71, 103]. 
Apart from regulation at the transcriptional level, telomerase activity can also be 
regulated by alternative splicing of the hTERT transcript, post-transcriptional 
modification, posttranslational modifications, protein-protein interactions as well as 
the assembly and translocation of the telomerase complex [18, 31, 100]. In this study, 
we would focus on a potent telomerase regulator which interacts with telomerase 
called PinXl, and its characteristics will be discussed in the later part. 
1-4.2.2 Regulation of telomerase activity by cellular components in ESCs 
Some highly expressed molecules found in ESCs which are essential for pluripotency 
and self-renewal are indeed regulators of telomerase expression. One example is 
c-Myc, which was found to regulate TERT positively at the transcriptional level [94, 
101]. In ESCs culture, LIF is used for maintaining the stem cell characteristics by 
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activating the downstream STATS pathway. In fact, STAT3 is also a positive 
regulator of TERT expression [42]. All these studies suggest that those molecules 
that are highly expressed in ESCs and are essential for stem cell characteristics may 
also be important regulators for telomerase, thereby preventing cellular aging. 
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1.5 PinXl 
The flill name of PinXl is Pin2/TRF1-interacting protein. PinXl was first discovered 
as a Pin2/TRF 1 -interacting protein in a human HeLa cell yeast two-hybrid cDNA 
library using Pin2 as a bait by Zhou et al in 2001 [112]. They firstly detected the 
45kDa PinXl protein in HeLa cells using specific antibodies. The mouse PinXl 
cDNA was also cloned by PGR later by the same group [112]. Mouse PinXl was 
found to encode a protein with �74o/o identical to the human one. PinXl ORF was 
also found in other eukaryotic cells including yeast and C. elegans, with �50o/o 
similarity to the human one, hinting the conservation of this protein among different 
species [112]. Human PinXl was found to be a potent telomerase inhibitor; it 
inhibited telomerase activity, shorten telomere length and promoted cellular crisis in 
a telomerase positive fibrosarcoma cell line [112]. Since then, PinXl has been widely 
studied for its function in telomerase regulation in a variety of cancer cells as 
up-regulated telomerase activity accounts for cancer cell immortality. 
1.5.1 Expression of PinXl 
PinXl was found to be ubiquitously expressed in various normal tissues in different 
species [51, 52, 68, 84]. Interestingly, hPinXl expression decreased in a variety of 
human cancers [41, 51]. A previous study showed that PinXl and telomerase 
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expressions were temporally regulated during Xenopus embryonic development: 
mRNA of both genes were expressed robustly during early embryogenesis and their 
expression decreased upon further development [91]. However, whether PinXl is 
expressed at the very early stage of mammalian development at protein level and 
whether its expression changes upon differentiation are unknown. 
1.5.2 Effects of PinXl on the activities and the sub-cellular localization of 
telomerase 
Distinct from other proteins that modulate telomere length without affecting 
telomerase activity per se, PinXl was found to directly bind to telomerase and inhibit 
telomerase activities in several species [54, 84, 112]. In addition, both hPinXl and 
yeast homolog of PinXl were found to decrease cellular telomerase activity by 
sequestering TERT in the nucleolus [53, 54]. However, whether these functions are 
conserved in mPinXl and mPinXlt (which lacks the C-terminal of mPinXl, will be 
discussed later), and whether the functions would have any impact on ESC 
characteristics remain unknown. 
1.5.3 Structure-function relationship of PinXl 
N-terminal of PinXl consists of a glycine-rich domain (G-patch) which is highly 
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conserved among species [51, 52’ 68, 84]. G-patch is known to bind to RNA and is 
frequently found in RNA-processing proteins, and yeast PinXl was found to be 
involved in rRNA processing and small nucleolar RNA maturation [36]. 
hPinXl was found to inhibit telomerase activity through its telomerase inhibitory 
domain (TID) at the C-terminal (254-326 amino acids in hPinXl) [16, 112]. 
Interestingly, over-expression of C-terminal alone inhibited telomerase activity and 
decreased cell growth to a larger extent than full-length hPinXl [112], hinting that 
the hPinXl N-terminus may activate cellular telomerase activity and promote cell 
growth. To study the functions ofN-terminal of PinXl, few groups had tried to clone 
the N-terminal of PinXl and established the N-terminal over-expressing cell line 
112]. However, generation of N-terminal 1-142 amino acids over-expressing cell 
line was not successful in one group [112], while another group successfully 
generated a longer N-terminal 1-289 amino acids over-expressing cell line and found 
that although telomere length was extended, no change in telomerase activity and cell 
proliferation could be detected [16]. Therefore, the difference of the mechanism 
between the two termini on the regulation of telomerase activity and telomere is still 
largely unknown. 
In addition, C-terminal and N-terminal regions of hPinXl were shown to be 
important for its own nucleolar localization or exhibit inhibitory effect on its own 
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nucleolar localization, respectively [107]. Since PinXl was found to sequester TERT 
in nucleolus and led to the unavailability of TERT to telomere [53, 54], C-terminal 
and N-terminal of PinXl may have differential roles in regulating telomerase activity 
at the cellular level. 
1.5.4 Effect of PinXl on the growth rate of normal and cancer cells 
Overexpression of hPinXl has resulted in a decreased cancer cell growth and 
senescence [51, 112]. Although the knocking down ofhPinXl in normal liver cells 
was found to enhance cell growth [51], decreasing hPinXl expression did not lead to 
detectable difference in the growth rate of cancer cells [112]. On the other hand, 
there are also contrasting findings showing that hPinXl knockdown led to growth 
inhibition in cancer cells [110]. It was suggested that silencing PinXl affected a 
telomerase-dependent pathway, causing apoptosis in a DNA damage stress condition, 
which would in turn affect telomere length maintenance. It is unclear whether the 
cellular effect is mediated through the telomerase inhibitory effect of PinXl. 
Altogether, Ml characterization of PinXl on its role in maintaining growth of cells 
(including ESCs) is necessary. 
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1.5.5 Other functions of PinXl 
Besides regulation of telomerase activity, PinXl is also involved in some other 
cellular processes like mitosis. It was found that PinXl could bind to microtubule 
and is essential for chromosome segregation during mitosis [108]. Another study also 
revealed that PinXl interacts with a chromosome periphery protein called nucleolin, 
and this interaction is important for a faithful chromosome congression during 
mitosis [50]. On the other hand, PinXl was also found to be involved in rRNA and 
small nucleolar RNA maturation, in agreement with its nucleolar localization [36]. 
1.5.6 Mouse homolog of PinXl and its function in mESCs 
PinXl homolog was found to be present in various species from yeast to humans [36, 
52, 68, 84, 91, 112]. The mouse homolog of PinXl was previously cloned and 
protein was found to be �74o/o identical to hPinXl protein [112]. By Zhou et al., 
mouse PinXl was found to play a role in regulating telomerase activity and 
maintaining chromosome stability. Both PinXl heterozygosity and knock-down in 
mouse embryonic fibroblasts led to activated telomerase and chromosomal instability 
[111]. However, its role in mouse ESCs is still unknown. In addition, in a PGR 
experiment amplifying the coding region of mPinXl gene, we have discovered a 
novel splice variant of mPinXl gene in ESCs. This novel splice variant encodes a 
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polypeptide chain with the N-terminal but not the C-terminal ofmPinXl (we named 
it as ‘mPinXlt，where ‘t, stands for the 'truncated' form of mPinXl). The possible 
role of this novel mPinXlt in maintaining the characteristics of ESCs is entirely 
unknown. Moreover, whether this mPinXlt would have any effect on telomerase is 
also unexplored. On the other hand, this naturally occurring mPinXlt could provide a 
good opportunity to understand the cellular function ofmPinXl N-terminal. 
Previous studies in the field focused on the importance of PinXl as a tumor 
suppressor [41, 51, 112]. The importance of PinXl in ESCs, which have uniquely 
high telomerase activity, has not been explored. Since ESCs have uniquely high 
telomerase activity, PinXl may play important functions in ESCs, thus it would be 
worth to investigate the role of PinXl in determining ESC characteristics. 
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1.6 Aims of this study 
Since mESCs have uniquely high telomerase activity, mPinXl, which is a potent 
telomerase regulator by interacting with it, may play important fiinctions in 
maintaining mESCs characteristics. Besides, we have discovered a novel splice 
variant of mPinXl gene, mPinXlt, in mESCs. This novel splice variant encodes a 
polypeptide chain with the N4erminal but not the C-terminal of mPinXl, and the 
possible role of this novel mPinXlt in maintaining the characteristics of mESCs is 
entirely unknown. Therefore, the main aims of this study were: 
1. to investigate the expression pattern of mPinXl and mPinXlt in mESCs and their 
differentiation derivatives, and also in adult mouse tissues. 
2. to investigate the sub-cellular localization ofmPinXl and mPinXlt in mESCs. 
3. to investigate the interaction between mPinXl and mPinXlt with mTERT. 
4. to over-express and knockdown mPinXl and mPinXlt in mESCs so as to 
investigate their roles in maintaining mESCs characteristics; cell proliferation, cell 
viability, telomerase activity, cell cycle progression, pluripotency and differentiation 
potential were investigated 
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CHAPTER TWO MATERIALS AND METHODS 
2.1 mESC culture and differentiation 
2.1.1 Cell line 
The mESC line D3 was derived from blastocysts of a 129S2/SvPas mouse. It was 
purchased from American Type Culture Collection (ATCC). Human embryonic 
kidney cell line HEK 293 FT was purchased from Invitrogen. 
2.1.2 Irradiation of MEF 
MEF medium was aspirated from the T75 flask. The flask surface was washed with 5 
ml PBS and then aspirated. 4ml 0.05% trypsin-EDTA solution was added and the 
o 
cells were incubated at 37 C for 3 minutes to dislodge cells. 5 ml MEF medium was 
added to neutralize trypsin reaction. The mixture was then pooled into a 50ml falcon 
o 
and centrifuged at lOOOrpm, 4 C for 5 minutes. Supernatant was removed.. Cell 
counting was performed after resuspension with fresh medium. Cells required to 
plate for use was reconstituted to 20ml cell suspension and irradiated by gamma 
irradiation at 7400 rads for X minutes. Irradiated cells were transferred on ice and 
o 
centrifuged at lOOOrpm, 4 C for 5 minutes. Supernatant was removed and the cell 
pellet was resuspended in MEF medium. Cell number was counted again and cell 
5 
suspension was further diluted to 1.4 X 10 cells per ml. 2 ml of cell suspension were 
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placed on gelatin-coated 6-well dishes and incubated at 3 7 � C with 5% CO^ supply 
overnight to allow cells to attach. 
2.1.3 mESC culture 
mESCs were cultured on a 6-well plate seeded with irradiated CD-I MEF feeder 
layer. Spent medium was aspirated and washed by 1ml PBS. Then, 1 ml of 0.05% 
trypsin-EDTA was added and the plate was incubated in 37 incubator for 5 
minutes. After the plate was transferred to the cell culture hood, 1ml medium was 
then added to each well to stop trypsin reaction. Cell suspension was centrifuged at 4 
o 
C, lOOOrpm for 5 minutes. Supernatant was removed, cell pellet was resuspended in 
mESC undifferentiated media containing DMEM supplemented with 15% FBS, 
2mM L-glutamine, O.lmM NEAA, O.lmM p-mercaptoethanol, lOOOU/ml LIF, 
50U/ml penicillin and 50|Lig/ml streptomycin. One-tenth of cells were made up in 2.5 
ml per one well of 6-well plate and seeded on fresh CD-I irradiated MEF for passage. 
o 
The plate was returned to the 37 C incubator with 5% CO^ supply. Cell culture 
media was refreshed daily for two to three days before next passage. 
2.1.4 Differentiation of mESCs 
mESCs were trypsinized and resuspended in undifferentiated medium as described 
previously. Part of the mESCs were seeded on MEF for passage, while the remaining 
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cells were seeded on 0.1% gelatin-coated 100mm Petri dish and incubated at 37 "c 
incubator for 30 minutes. This can remove MEF in cell mixture so as to increase the 
purity of mESCs for differentiation. After 30 minutes, cells were centrifuge at 4 
lOOOrpm for 5 minutes. Supernatant was removed and cell pellet was resuspended in 
mESC differentiation medium containing DMEM supplemented with 15% FBS, 
2mM L-glutamine, O.lmM NEAA, O.lmM (3-mercaptoethanol, 50U/ml penicillin 
and 50^g/ml streptomycin. Cells were counted and differentiation medium was 
added so that the cells were resuspended at a concentration of 4 X 10^ cells/mL. 
Hanging drops were made at 800 cells per 20fil hanging drop. 50 hanging drops were 
placed on the lid of 100 mm Petri dish carrying 20 ml PBS to prevent drying of 
hanging drops. Petri dish with hanging drops was incubated at 37 with 5% CO 
2 
supply for 2 days. 
On differentiation day 2, embryoid bodies (EBs) developed in hanging drops were 
monitored under inverted microscope to ensure single ball shape EB with normal 
size was formed in every hanging drop. Then, EBs were washed into 100 mm 
bacterial grade petri dish in 10ml suspension and incubated in 37 incubator with 
5% CO^ supply for 5 days. 
On differentiation day 7, each EB were seeded onto one well of 0.1% gelatin coated 
24-well plate with 1ml differentiation medium. The EBs were allowed to attach in 
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o 
37 C incubator with 5% CO^ supply overnight. The percentage of beating EBs was 
counted from differentiation day 7+1 to day 7+12. EBs were collected on required 
days for subsequent applications. 
2.1.5 Establishment and culture of feeder-free mESCs 
The mESC line D3 was first cultured on a feeder layer of irradiated MEFs on 
gelatin-coated culture dishes. After trypsinization, the cells were transferred to a 
gelatin-coated dish, incubated at 3 7 � C for 30 minutes and passed to other 
gelatin-coated dishes for subsequent culture. The cells were cultured for four more 
passages until no MEF could be observed under microscope. The feeder-free mESCs 
were then kept as a continuous culture, some of which were frozen and stored for 
future use. 
2.1.6 Culture of feeder-free mESCs 
Feeder-free mESCs were cultured on 0.1% gelatin coated 6-well culture plate. They 
were maintained in an undifferentiated state by the culture medium which consisted 
o fDMEM supplemented with 15% FBS, 2mM L-glutamine, O.lmM NEAA, O.lmM 
p-mercaptoethanol, lOOOU/mL LIF，50U/mL penicillin and 50|ig/mL streptomycin. 
o 
The cells were incubated at 37 C incubator with 5% CO^ supply. The culture 
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medium was changed daily. 
2.2 Trypan Blue Exclusion Assay 
mESCs seeded on 12-well culture plate was trypsinized and collected in 1.5ml 
eppendorfs. Each well of cells was resuspended by lOOfil medium. I0\xl of the cells 
were mixed with 10|il of trypan blue and lOjil of the mixture were placed into a 
haemocytometer for counting of the number of dead cells (with blue staining) and 
viable cells (without blue staining). The total number of dead and viable cells in each 
well was found by multiplying the counted number with the dilution factor. 
2.3 Sub-cloning 
2.3.1 Amplification of the insert gene by PCR 
Pairs of primers were designed to flank the coding region of sequence the gene with 
the addition of restriction site at both 5' and 3' primer. Polymerase chain reaction 
(PCR) was performed in a 50|il mixture with 0.3|aM each of the primers, IX Pfx 
amplification buffer, 0.3mM dNTP mixture, ImM MgSO^, l|Lig template DNA and 1 
unit of Platinum Pfx DNA polymerase (Invitrogen). PCR reaction was performed by 
denaturing at 94 C for 2 minutes, followed by 35 cycles of amplification at 94 C for 
O o 
15 seconds, 55 C for 30 seconds, 68 C for 1 to 3.5 minutes, with a final extension at 
o 
68 C for 30 seconds. For mPinXl, the primers were designed according to the 
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mPinXl mRNA NCBI reference sequence NM—028228.3. For mTERT, the primers 
were designed according to the mTERT mRNA NCBI reference sequence 
NM—009354.1. Suitable restriction sites were added to the primers for subsequent 
restriction digestions. 
Construct ,, 
pTriEx4-mPinX 1 / Forward (EcoRI) 1 m i n ^ Diff. Day 7+25 ， 
pTriEx4-mPinXlt r^GGGAATTCATCAGCGTTCGAC A A A CTTGA G mESCs cDNA 
Reverse (Not!) 
rA4GGGCGGCC^ACAGTTGAGTGGTTGGAGGC 








pCMV-HA-mPinXl/ Forward (EcoRT) 1 min pTriEx4- mPinXl 
pCMV-Myc-mPinXl ^GCGGAATTCAGATGTCGATGCTAGCA 
Reverse (Not!) 
H G C G G C C G C T T A T C T G G A A A CTTTC 
pCMV-HA-mPinX 11/ Forward (EcoRI) 1 min pTriEx4-mPinX 11 
pCMV-Myc-mPinX 11 yjfGCGGA ATTC AGATGTCGATGCTA GCA 
Reverse (Not!) 
v4C4rGCGGCCGCTTAGTCATGCAGAACA 
pCMV-HA-mTERT/ Forward (EcoRI) 3.5 mins pcDNA-mTERT 
pCMV-Myc-mTERT 乂TUJGAATTCAGATGACCCGCGCTCCTC (Kindly provided 
Reverse (Not!) by Prof. Fuyuki 
ACATGCGGCCGCTTAGTCCA A A ATGGTr Tshikawa, Kyoto 
University) 
pWPI-Myc-mPinX 1 Forward (Swal) 1 min pWPXL-mPinX 1 
GGCCATTTA A ATATGGCATCAATGC A G A = — 
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Reverse (Pad) 
CGGCTTAATTAATTATCTGGA AACTTTC 
pWPl-Myc-mPinXlt Forward (Swal) Wnhi pWPXL-mPinXlt 
GGCCATTTA A ATATGGCATC A ATGCAGA 
Reverse (Pad) 
CGGCTTAATTAATTAGTCATGCAGAACA 
Table 2.1 Forward and reverse primers used for amplification of genes in sub-cloning. 
For each primer, a restriction site was added as indicated by the blanket; the 
restriction site sequence was underlined. The clamp sequence was shown in italic. 
The additional bases added to prevent frame shift was indicated in bold. The specific 
extension time and template used for each amplification was also shown in the table. � 
2.3.2 Purification of PGR products 
PCR products were separated by electrophoresis in a 1% TAE agarose (Tnvitrogen) 
gel with 0.7 jig/ml ethidium bromide (Invitrogen). The PCR products were visualized 
T M 
on a 2UV Transilluminator and then excised out and weighted. The DNA in gel 
pieces were purified using QTAquick DNA Extraction Kit (Qiagen) according to 
manufacturer's instructions. Briefly, the excised gels were dissolved in 3 gel weight/ , 
volumes (g/mL) of QC buffer at 55°C for 10 minutes with occasional shaking. One 
gel weight/ volume of isopropanol was added to the dissolved mixture. The mixture 
was allowed to flow through QIAquick spin column that connected to a 2 ml 
collection tube. The column was then subjected to centrifugation at 13,000 rpm for 1 
minute. The flow through was discarded and the column was washed once with 
700jLil PE buffer. The column was centrifliged at 13,000 rpm for a minute and the 
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flow through was discarded. The column was centrifliged again to remove any 
residual buffer. 30|LI1 of autoclaved double distilled water was added and incubated 
for 2 minutes at room temperature and eluted by centrifligation at 13,000 rpm for 1 
minute. The concentration of DNA was determined by using a Nano-drop 1000 
Sepctrophotometer (Thermo Scientific). 
2.3.3 Restriction enzyme digestion 
For double digestion, it was performed in a 20|LI1 reaction mixture containing l\ig of 
PCR product/ vector, 3 units of the two restriction enzymes (New England Biolabs), 
IX BSA, IX NEB buffer and autoclaved double distilled water. The incubation time 
and temperature of the reaction mixture depends on the restriction enzymes used. For 
serial single digestions, it was first performed in a 20|il reaction mixture containing 
Ifig of PCR product/ vector, 10 units of the restriction enzyme (New England 
Biolabs), IX BSA, IX NEB buffer and autoclaved double distilled water, then the 
reaction mixture was incubated at a temperature and for a time depending on the 
enzyme used. The enzyme was then heat inactivated and the PCR/vector is digested 
with another restriction enzyme by topping up the reaction mixture to 40|il with 10 
units of the restriction enzyme (New England Biolabs), IX BSA, IX NEB buffer and 
autoclaved double distilled water. The digestion products were analyzed on a 1% 
TAE agarose gel and the target bands were excised and purified as described in 
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section 2.3.2. 
Construct ” , J InsertA^^or cut by �,暴�'(:,�坊中Iiiai^atioiii;::^^；] 
‘ • "‘’ ‘ ‘ ‘ , •/" ‘‘ ‘ . / • ‘ ‘ '/" '7'“广'''/''//' 
• 、 ' . 广 , ：：':'‘',.: ;';。、,;:？。; '）：’ condition 
pWPXL-mPinXl Insert: Bell, Mlul 37 Overnight 
Vector: BamHI, Mlul 3 7 ° C , 2 h o u r s 
pWPXL-mPinX 11 Insert: Bell, Mlul 3 7 Overnight 
Vector: BamHT, Mlul 3 7 � C , 2 hours 
pCMV-HA-niPinX 1 / Insert: EcoRI, Not! 37 o q 2 hours 
pCMV-Myc-mPinXl Vector: EcoRI, NotI 
pCMV-HA-mPinXlt/ Insert: EcoRI, NotI 37°C , 2 h o u r s 
pCMV-Myc-mPinXlt Vector: EcoRI, Not! 
pCMV-HA-mTERT/ Insert: EcoRI, NotI 37^0, 2 hours 
pCMV-Myc-mTERT Vector: EcoRI, NotI 
pWPT-Myc-mPinXl Insert: Swal, P a d Swal: 37 "C 1 
hour, heat 
Vector: Swal, P a d inactivate at 
65 "C, then P a d : 
25 ^C 1 hour 
pWPT-Myc-mPinXlt Insert: Swal, P a d Swal: 37 "C 1 
hour, heat 
Vector: Swal, P a d inactivate at 
65 °C, then P a d : 
25 1 hour 
Table 2.2 Restriction enzymes used in sub-cloning. For generation of each construct, 
the restriction enzymes and specific condition used were listed in the table. 
»« * 
2.3.4 Ligation of digested insert and vector 
Ligation of the purified digested insert and vector was performed in a 30|il reaction 
mixture containing 50ng of vector, insert in a 3:1, 5:1 and 8:1 mole ratio to vector, 
IX ligation buffer, 600 units of T4 DNA ligase (New England Biolabs) and 
autoclaved double distilled water. A negative control reaction was included in 
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parallel by replacing DNA insert with water. The reaction mixture was incubated at 
o 
16 C overnight for ligation. 
2.3.5 Transformation of ligation product into competent cells 
The frozen competent cells E. coli strain DH5a cells were thawed on ice. I5[i\ 
ligation mixture was mixed with lOOjil competent cells and incubated on ice for 20 
minutes. The cells and DNA mixture was then heat shocked at 42 for 90 seconds 
followed by chilling on ice for 3 minutes. After that, 800|il LB medium was added 
for recovery and cells were incubated at 37 for 40 minutes under shaking at 
250rpm. After incubation, bacterial cells were subjected to centrifugation at 13,000g 
for 1 minute in Eppendorf Centrifuge 5415R. The supernatant was discarded; the cell 
pellet was resuspended in the remaining supernatant and was spread onto LB agar 
plate containing ampicillin (50fig/ml). The plate was incubated at 37 for 
overnight. 
2.3.6 Confirmation of positive clone by colony PCR 
The single colonies were picked from the LB agar plate and were seeded onto 
another plate where they were assigned with a number. Then the plate was incubated 
o 
at 37 C overnight. Some of the cells from the colonies were used to perform the 
colony PCR to check the existence of the insert in the colony. PCR mixture was 
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prepared in a 25|liI mixture with IX PGR buffer (10 mM Tris-HCl (pH 9.0), 50mM 
KCl), 0.2mM dNTP mixture, 1.5mM MgCl� ’ 1 unit Taq polymerase (Genesys. Ltd.), 
0.5mM of forward and reverse primers used in the first step of amplification, and 
autoclaved double distilled water. The reaction was performed by denaturing at 94°C 
for 3 minutes, followed by 35 cycles of amplification at 94"C for 30 seconds, 56°C 
for 1 minute, 72°C for 1-3.5 minutes, with a final extension at 72°C for 7 minutes. 
The PGR products were analyzed on a 1% TAE agarose gel. 
2.3.7 Small scale preparation of the recombinant plasmid DNA 
Colonies were picked from the second LB agar plate and inoculated in 5ml LB 
medium containing 50|Lig/ml ampicillin and incubated at 37°C, 250rpm for 16 hours. 
The bacteria were harvested by centriftigation at 6,000g for 3 minutes in Eppendorf 
Centrifuge 5415R on the next day. The small scale preparation of bacterial plasmid 
DNA was done by QIAprep Miniprep Kit (Qiagen) according to manufacturer's 
instructions as follows. The cell pellet was resuspended in 250^1 chilled PI Buffer. 
Then, 250|il P2 Buffer was added to cell suspension to lyse the cells. 350|li1 N3 
Buffer was subsequently added to neutralize the lysis buffer and cells were subjected 
to centrifugation at 13,000rpm for 10 minutes. The supernatant was then applied to 
the QIAprep spin column and centrifliged for another minute. The flow through was 
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discarded and the QIAprep spin column was washed once by addition of 0.75ml PE 
Buffer followed by centrifligation at 13,000rpm for 1 minute. An additional 
centrifiigation at 13,000rpm for 1 minute was performed to remove any residual 
wash buffer. Finally, QIAprep spin column was placed in a clean 1.5ml tube and 
30|il pre-warmed autoclaved double distilled water was added to the centre of the 
c - “ 
column. The column was let stood for 1 minute and DNA was then eluted by 
centrifligation at 13,000 rpm for 1 minute. The concentration of DNA was 
determined by using a Nano-drop 1000 Sepctrophotometer (Thermo Scientific). 
2.3.8 Confirmation of positive clone by restriction digestion 
The prepared recombinant plasmids were double digested by specific restriction 
enzymes to confirm the successful ligation of the insert and the vector. The digestion 
procedure was performed as mentioned in 2.3.3. 
2.3.9 DNA sequencing of the recombinant plasmid DNA 
DNA sequencing of the recombinant plasmid DNA was performed by the 
i -
commercial sequencing service TechDragon Company with a vector specific forward 
primer and gene specific internal primers. 
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2-3.10 Large scale preparation of the recombinant plasmid DNA 
After verification of the positive clones, lOOjil of bacteria with target insert were 
inoculated into 200ml LB medium containing ampicillin (50^g/ml). The culture was 
• o 
incubated at 37 C with shaking at 250 rpm for 16 hours. Next day, the bacterial cells 
were harvested by centrifugation at 4400rpm at room temperature for 15 minutes. 
The large scale preparation of confirmed bacterial plasmid DNA was done by 
QIAprep Midiprep Kit (Qiagen) according to manufacturer's instructions as follows. 
After the supernatant was removed, the bacterial pellet was resuspended in 6 ml 
chilled PI Buffer. Afterward, 6 ml of P2 Buffer was added, mixed by inverting the 
sealed tubes 4-6 times, and incubated for 5 minutes to lyse the cells. The resultant 
viscous cell lysate was then neutralized by 6 ml chilled P3 Buffer. The lysate was 
then poured into the barrel of the QIAfilter Cartridge and incubated at room 
temperature for 10 minutes. The cap from the QIAfilter outlet nozzle was then 
removed and a plunger was gently inserted into the QIAfilter Cartridge to filter the 
cell lysate into a previously QBT Buffer-equilibrated HiSpeed Tip. The clear lysate 
was allowed to enter the resin by gravity flow. When all lysate was flown through, 
the HiSpeed Tip was washed with 20 ml QC Buffer and DNA was eluted with 5 ml 
QF Buffer. The DNA eluted was then precipitated by mixing with 3.5ml isopropanol 
and incubated at room temperature for 5 minutes. The precipitated DNA was 
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subsequently passed through a QIAprecipitator under constant pressure for 3 times 
and washed with 2 ml 70% ethanol. The QIAprecipitator was then dried by pressing 
air through it for several times and is allowed to air dry for 15 minutes. Finally, the 
DNA was eluted by 1ml pre-warmed autoclaved double distilled water. The 
concentration of DNA was determined by using a Nano-drop 1000 
Sepctrophotometer (Thermo Scientific). 
2.4 Design of siRNA targeting mPinXl and mPinXlt 
The siRNA of mPinXl and mPinXlt were designed and synthesized by the 
Silencer® Custom Designed siRNA (Ambion). The knockdown efficiency of the 
siRNA were tested by transfection of the siRNA into mESCs followed by qPCR. 
Silencer® Negative Control #1 siRNA (Ambion) were used as the control scrambled 
siRNA. 
siRNA . • , :�I• Sequence's，.輪‘3，':。:？ ； , 广: ‘ .,..…......,„. •' 、丨丨 . . . . . . … . � . / . i h > <一 ...、, < ‘ 
mPinXl siRNA (sense) CAAGAAGCUUGCUCAGGAUTT 
mPinXlt siRNA 1 (sense) GCAUGACUAAGAGAAGAAATT 
mPitiX 11 siRNA 2 (sense) CUUUGCCAGAUUAAGAUUGTT— 
Table 2.3 List of siRNA used in transient knockdown experiments 
2.5 Transient transfection 
4 
One day before transfection, 3-10 x 10 cells were plated on each well of 12-well 
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plate. On the day of transfection, medium was aspirated, cells were washed with PBS 
and 1ml of medium without antibiotics was added back. Plasmid DNA/ siRNA 
transfection was done with Lipofectamine 2000 (Invitrogen) according to 
manufacturer's instructions as follows. 1.6昭 of plasmid DNA/ 60pmol of siRNA 
were diluted in 100|il of Opti-MEM I Reduced Serum Medium. At the same time 
2-4|al of lipofectamine was diluted with 100|il of Opti-MEM I Reduced Serum 
Medium in another tube. They were incubated at room temperature for 5 minutes. 
Then the diluted plasmid DNA/ siRNA and lipofectamine were combined and 
incubated for another 20 minutes at room temperature. After the incubation, the 
were added to each well containing the cells and medium drop by drop The 
cells were put back into the 3 7 � C incubator with 5% CO^ supply. Medium was 
changed after 4-6 hours. Medium was changed daily and cells were collected at 24, 
48 and 72hrs after transfection. The transfection could be scaled up or down 
according to manufacturer's instructions. 
2.6 Cloning of siRNA into shRNA insert in Lentiviral Vector pLVTHM 
The siRNA of mPinXl was designed and synthesized by the ！Silcnccr® Custom 
Designed siRNA (Ambion) and the scrambled version of the siRNA was generated 
by siRNA Wizard V3.1 Online. The sequences were shown in Table 2.4. The 
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sequence ofmPinXl siRNA and the scrambled siRNA were applied for the design of 
shRNA insert which generated Clal and Mlul sticky ends after annealing according 
to the suggestion from Tronolab (http://tronolab.epfl.ch/) as shown in Table 2.5. The 
oligos were ordered at SOnmole scale and dissolved in autoclaved double distilled 
water to get a concentration of lOOjiiM. The oligos were annealed to form double 
strand inserts by mixing lOOOpmol of sense and antisense oligos in IX Annealing 
Buffer (lOOmM K Acetate, 30mM HEPES at pH7.4, 2mM Mg Acetate) and 
autoclaved double distilled water. The annealing mixture was initially heated to 95°C 
for 5 minutes, then the temperature was touched down to 6TC in 28 cycles (1 minute 
each). The mixture was maintained at 6 7 � C for 30 minutes and then touched down 
again in 42 cycles (1 minute each) to reach 20°C which complete the annealing 
process. 5jLil of annealed oligos were then subjected to phosphorylation by T4 PNK 
Kinase in IX T4 Buffer (New England Biolabs) and autoclaved double distilled 
water. The phosphorylation process lasted for 30 minutes followed by 10 minutes 
heat inactivation of the T4 PNK Kinase at 70�C. The Lentiviral Vector pLVTHM was 
sequentially digested with restriction enzymes Clal and Mlul for subsequent ligation. 
Firstly, 2\ig of pLVTHM was digested by 10 units of Clal (New England Biolabs) in 
IX NEB buffer 4 and IX BSA with autoclaved double distilled water at 37°C for 60 
minutes followed by heat inactivation of Clal at 65�C for 20 minutes. Subsequent 
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Mlul digestion was carried out by topping up the reaction mixture to 40|il with 20 
units of Mlul (New England Biolabs) in IX NEB buffer 3 and IX BSA with 
autoclaved double distilled water at 3 7 � C for 90 minutes followed by heat 
inactivation of Mlul at 65�C for 20 minutes. The digestion product of pLVTHM 
was separated in 1% TAB Agarose (Invitrogen) gel. The gel was excised out with the 
aid of 2UVTm Transilluminator and subjected to Gel Extraction (QIAGEN) process 
as mentioned in section 2.3.2. 20 to lOOng of digested pLVTHM were used to ligate 
with 5|il of phosphorylated oligos by T4 DNA Ligase in T4 Buffer (New England 
Biolabs) and autoclaved double distilled water. The ligation mixture was prepared in 
duplicate, one tube was incubated at 4°C for 48 hours, another tube was incubated at 
16°C for 48 hours. The ligated plasmid with the mPinXl siRNA and the Scrambled 
mPinXl siRNA were named as shPinXl and shScrambled, respectively. 
S i R N A , � … , “ 
mPinXl siRNA (sense) AAGAAGAAAGTTTCCAGATAA 
Scrambled mPinXl siRNA (sense) GAAACAGATAATAGACAGTTA 
Table 2.4 List of siRNA for cloning into pLVTHM. The mPinXl siRNA sequence 
was designed by Ambion while the scrambled siRNA sequence was generated by 
siRNA Wizard V3.1 Online. 
i ‘ 
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Sense mPinXl shRNA oligo: 
CGCGlCCCCAAGAAGAAAGTTTCCAGATAAttcaagaga 
TTATCTGGAAACTTTCTTCTTTTTTTGGAAAT 
Antisense mPinXl shRNA oligo: 
CGMTTCCAAAAAAAGAAGAAAGTTTCCAGATAAttcaagaga 
TTATCTGGAAACTTTCTTCTTGGGGA 
Sense Scrambled mPinXl shRNA oligo: 
CGCGICCCCGAAACAGATAATAGACAGTTAttcaagaga 
TAACTGTCTATTATCTGTTTCTTTTTGGAA^ 
Antisense Scrambled mPinXl shRNA oligo: 
CGMTTCCAAAAAGAAACAGATAATAGACAGTTAttcaagaga 
TAACTGTCTATTATCTGTTTCGGGGA 
Table 2.5 List of shRNA Oligo Insert for pLVTHM subcloning. The oligos were 
designed according to Tronolab. Annealing the sense and antisense oligos would 
raise a 5' Mlul sticky end and a 3' Clal sticky end indicated by underline. The 
boMed sequences are showing the sense and antisense siRNA which would anneal to 
form a hairpin after transcription with the loop shown in small letters. 
2.7 Lentiviral vector-mediated gene transfer to mESCs 
2.7.1 Lentivims packaging 
6 
2X10 HEK293FT at early passage were plated on T25 flask a day before 
transfection in 3ml medium. DNA constructs and the packaging plasmids (psPAX2 
and pMD2.G) were co-transfected into the HEK293FT cells as described below. 
Two reaction mixtures were prepared in 15ml falcon; both contained 0.63ml 
OPTI-MEM (Invitrogen). 4.2^g psPAX2, LOSjig pMD2.G and 2.1 jag DNA construct 
were incubated with OPTI-MEM in the first falcon; while 21jil lipofectamine 2000 
was incubated with OPTI-MEM in the second falcon. The two reaction mixtures 
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were allowed to incubate at room temperature for 5 minutes. They were mixed gently 
together and stood at room temperature for another 20 minutes. At the same time, 
spent medium of HEK293FT was replaced with 3ml of OPTI-MEM medium. After 
20 minutes, the reaction mixture was added to the HEK293FT cells and incubated at 
O 
37 C for 6 hours. OPTI-MEM I medium with the complexes was changed back to 
normal medium after 6 hours and lend viruses were collected at 24, 48 and 72 hrs 
post-transfection. 
2.7.2 Checking of successful transduction by lentivirus in HEK cells 
4 
On day 1, 1x10 HEK293FT cells were plated on each well of 24-well plate in 0.5ml 
medium. On the next day, each well of the cells were transduced with 200|al of virus 
and topped up with 200|il of medium with 6|Lig/ml polybrene. On day 4, the cells 
were seen under fluorescent microscope to investigate the transduction efficiency, 
and the batch of virus which gave the highest transduction efficiency and brightest 
green fluorescent signal were chosen for transduction in mESCs. 
2.7.3 Multiple transductions to mESCs 
4 
mESCs at passage 8 were used for vims transduction. On day 0, 1x10 mESCs were 
seeded on 12 well plates with MEFs. On day 1, 200|LI1 of virus, 200^1 of medium and 
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6jig/ml polybrene were added to each well. This transduction was repeated two more 
times at 12 hours and 24 hours after the first round of transduction. 12 hours after the 
final round of transduction, all viruses containing medium was removed and 500|il of 
fresh medium was added to each well for maintenance. 
2.7.4 Selection of positive clones 
Clones with brightest green fluorescent signal and morphology at undifferentiated 
state were selected. They were picked by glass pipettes in sterile hood under Lecia 
MZ95 microscope. The clones were washed with PBS and centrifuged at 3000rpm 
for 5 minutes. They were trypsinized for 3 minutes 3 7 � C and gently pipetted up and 
down for dispersion into single cells. Fresh medium were then added and the cells 
were centriftiged for 5 minutes at SOOOrpm. Supernatant was discarded, and the cells 
were resuspended in fresh medium and placed into 24-well plates seeded with MEFs. 
2.7.5 Monoclonal establishment 
After the single cells had formed observable clones, independent clones with bright 
green fluorescent signal were picked by glass pipettes in hood under Leica MZ95 
microscope. Each clone were gently dispersed by pipetting up and down and seeded 
to a 24-well. The independent clones were expended and cultured as usual with some 
4 4 
Chapter 2 Malerials and methods 
frozen up as stocks. For Pwpi-PinXl stable cell line, 4 clones were selected. For 
Pwpi-PinXlt, Pwpi only, shPinXl and shScrambed stable cell lines, 3 clones were 
selected. 
2.8 Total RNA preparation, Reverse Transcription (RT) and Quantitative 
Polymerase Chain Reaction (qPCR) 
Total RNA was extracted using Trizol reagent (Invitrogen) according to 
manufacturer's protocol. Extracted RNA was dissolved in DNase/RNase-free water 
(Gibco) and quantified by measuring absorbance at 260nm and 280mn (Thermo 
Scientific, NanoDrop ND-1000). Integrity of extracted RNA was confirmed by the 
presence of 28s and 18s rRNA by electrophoresis in 1% agarose gel. The resulting 
RNA was DNase I (Invitrogen)-treated and subjected to RT using SuperScript III 
reverse transcriptase (Invitrogen). RT was confirmed successful by PGR using the RT 
products as the templates and the GAPDH gene primers. For real-time qPCR, Power 
SYBR GREEN PGR Master Mix (Applied Biosystems) was used and qPCR 
reactions were performed with 7500 Fast Real-time PGR system (Applied 
Biosystems). Each reaction was performed at least in triplicate under the following 
conditions: 50°C for 2 minutes; 95°C for 10 minutes; 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute. Melting curve analysis and electrophoresis of PGR 
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products were performed to verify the authenticity of PCR products. For checking 
amplification efficiency by individual primer pairs, standard curve experiments were 
performed. The starting quantity of mESCs cDNA was 500ng and serial factor was 
1:10. Five points were used in the standard curve. Primer pairs with PCR efficiency 
of 90-110 % were used for further experiments. 
Fold-changes in the relative mRNA expression of the target gene were determined 
using the method in which the target gene was normalized to the housekeeping 
gene P-actin and the relative expression levels of different genes in experimental 
groups were normalized to that in control group. 
Primer Sequences Product GenBank accession 
————,...�..,：•、:.海r " : Size (bp) no. 
mPinXl ^ ~ 
5’ Primer CCACGGTCAGGAAACAGCAG W NM—028228.3 
3, Primer AGCCATCCTGAGCAAGCTTC 
~“ “ — / 
mPinXlt 
5, Primer AAAGGGAAGGATCTGTCCTC m / 
P r i m e r CC ATCTCC AGAC AATCTTAATC 
Table 2.6 List of primers used in RT-qPCR. The sequence of primer, product size and 
the GenBank accession number of the gene were shown in the table. 
2.9 Immunocytochemistry 
Cells were trypsinized and seeded onto glass slides pre-coated with gelatin. After the 
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cells were seated onto the glass slides, which took around 4-5 hours, they were 
washed with PBS and fixed with freshly prepared 4% PFA in PBS at room 
temperature for 30 minutes. After that the cells were washed twice with PBS each for 
15 minutes at room temperature, and then blocked with blocking buffer (0.5% (w/v) 
Non-fat dry milk (Bio-rad), 5% (v/v) Normal goat serum in PBS) at room 
temperature for 1 hour with gently shaking. The cells were then incubated with 
primary antibody diluted in blocking buffer overnight at 4 ^ C with gently shaking. 
On the next day, the cells were washed with washing buffer (0.1% Tween-20 (USB) 
in PBS) for 15 minutes. After 4 times of washing, the cells were stained with 
secondary antibody diluted in 1% normal goat serum in PBS for 1 hour at room 
temperature. After staining, the cells were washed with washing buffer for 15 
minutes, and after 4 times of washing, the cells were counterstained with 40|ag/ml 
propidium iodide with lOOfig/ml RNase A for 15 minutes at room temperature if 
desired. The stained cells were observed and imaged with Leica SP5 Confocal 
Microscope and software. 
Antibody used in ICC I Dihitioii 
Anti-Fibrillarin (Cell Signaling ) 1:1000 
Dylight 594 Goat Anti-Rabbit (Jackson) 1:1000 
Table 2.7 List of anti-body and the specific dilution used in ICC experiments. 
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2.10 Western Blot 
2.10.1 Total Protein Extraction 
Cells were harvested, washed with PBS once and lysed in ice-cold RIPA buffer 
containing PBS with 1% NP-40, 0.5% sodium deoxycholate, 1% SDS, 1% protease 
inhibitor cocktail [Leupeptin (Ijig/mL), Aprotinin (5|^g/mL), PMSF (lOOjig/mL), 
sodium orthovanadate (100|ig/mL), EGTA (200|ig/mL) and EDTA (200|ig/mL) and 
phosphatase inhibitor cocktail [NaF (250mM), P-glycerolphosphate (500|ig/mL) and 
HEPES (50mM, pH 7.3)]. The cell lysate was incubated on ice for 10 minutes, and 
centrifiiged at 16000g for 20 minutes at 4 � C . The supernatant was collected and the 
protein concentration was estimated by Bradford assay (Bio-Rad Laboratories). 
Aliquots of protein were stored at -80°C until performing electrophoresis. 
2.10.2 Measurement of Protein Concentration 
To determine the protein concentration, 200fil Bradford reagent was mixed with l\il 
of 10 fold diluted sample protein in a flat bottom 96-well plate in duplicate. Bovine 
serum albumin (BS A) standards of various concentrations were also included. After 
incubation for 5 minutes at room temperature, the absorbance reading of each well 
was taken by a microplate reader (Model 3550, Bio-Rad) at wavelength 595nm. 
Protein concentration of each sample was then determined directly from the BSA 
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standard curve. 
2.10.3 SDS-PAGE and chemiluminescent detection 
Aliquots of total protein were mixed in 1:1 ratio with Ix sample loading buffer 
containing 125mM Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 0.06% bromophenol 
blue and 10% p-mercaptoethanoL Depending on the molecular weight of target 
protein, samples were separated in 6-12.5% SDS polyacrylamide gel. Pre-stained 
Novex Sharp Standard marker (Invitrogen) was loaded in parallel as a standard 
molecular weight marker. The 4% stacking gel was electrophoresed at 70 volts for 30 
minutes while the separating gel was increased to 100-120 volts for 1.5-2 hours. 
After electrophoresis, the gel was electrophoretically transferred onto PVDF 
membranes (Millipore) with a Trans-blot SD wet transfer tetra-cell (Bio-Rad) at 100 
volts for 1.5-2 hours, duration of which depended on the size of target protein. 
Membranes were blocked for 1 hour at room temperature with 5% dried non-fat milk 
in Tris-buffered saline containing 0.1% Tween-20 (TEST). Incubation with primary 
antibodies was carried out at 4 � C overnight. For the determination of PinXl antibody 
specificity, antigenic peptides were pre-incubated with corresponding antibodies 
(10:1 w/w) in 500|il of PBS at room temperature for 2 hours before adding to 5% 
milk. After primary antibody probing, membranes were subjected to three washes in 
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TBST, each for 15 minutes with gentle shaking. Membranes were next incubated 
with HRP-conjugated secondary antibodies for 45 minutes at room temperature, 
followed by three 15-minute washes with TBST. Protein expression was detected by 
enhanced chemiluminescent substrate (ECL: Pierce) and protein bands were 
visualized by film exposure. TATA-box binding protein (TBP) or H3 were used as 
internal controls. The density of the bands was quantified using AlphaEaseFC 
software (Alpha Innotech). 
Primary Antibody used in Western blot | Dilution 
Anti-Sox2 (Abeam) 1:1000 
Anti-Oct4 (Santa Cruz) 1:400 
Anti-Nanog (Abeam) \: \ qqq 
Anti-Klf-4 (Abeam) \: \ qoo 
Anti-PinX 1 (Kindly provided by Prof. RC. Shaw, CUHK) 1 ： 1000 
Anti-H3 (Abeam) 1:10,000 
Anti-TBP (Abeam) 1:1000 
Anti-p tubulin (Santa Cruz) \: \ QOO 
Anti-Myc (Cell signalling) \: \ QOO 
Table 2.8 List of primary anti-body and the specific dilution used in western blot. 
, ' � “ ' ‘ �““ . “ . z” , I '••'• “‘ I ‘ ” 
Secondary Anti-body used in Western blot Dilution 
Goat Anti-Rabbit TgQ HRP conjugated (Dako) 1:5000 
Rabbit Anti-Mouse TgQ HRP conjugated (Dako) 1:5000 
Goat Anti-Rabbit IgQ HRP conjugated (Invitrogen) 1:10,000 
Table 2.9 List of secondary anti-body and the specific dilution used in western blot. 
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2.11 Co-immunoprecipitation 
5 
On day 1, 2 X 10 HEK cells were plated on each well of 6-well plate. For each well, 
l|ig of mTERT recombinant plasmid was mixed with l|Lig of mPinXl or mPinXlt 
recombinant plasmid, and 6|il of Lipofectamine 2000 was used. Transfection was 
done according to section 2.5. 48hrs after transfection, medium was removed and the 
cells were washed with 1ml PBS. The cells were harvested by scarper with 500jil IP 
buffer (50mM Tris pH 7.6, 150mM NaCl, ImM EDTA, 1% Triton XI00) in the 
presence of protease inhibitors and phosphatase inhibitors (l|ig/ml Leupetin, 5|ig/ml 
Aprotonin, 100|ig/ml PMSF, ImM Sodium Orthovanadate, ImM EGTA, ImM 
EDTA, ImM NaF, 2mg/ml p-glycerolphosphate). The cells were sonicated for a few 
seconds followed by centrifligation at 13,000rpm at 4 � C for 10 minutes. 200^1 of 
supernatant was topped up to 500|LI1 with IP buffer and anti-body at a specific dilution. 
The mixture was incubated at 4°C overnight with gently shaking. 
On the next day, 15|il of protein A-agarose beads (Sigma) was added to each reaction 
tube and incubated at 4 � C for 1.5 hours with gently shaking. After that, the beads 
were spun down at 13,000rpm for 10 seconds, supernatant was removed and the 
beads were washed with IP buffer. After 3 times of washing, 30fxl loading dye was 
added to each tube and the beads were boiled for 5 minutes followed by SDS-PAGE 
and chemiluminescent detection according to section 2.10.3. 
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Anti-body used in pull down I Dilution 
Anti-Myc (Cell Signaling) 1:500 
Anti-HA (Sigma) 1:500 
Table 2.10 List of anti-body and the specific dilution used in pull down during Co-IP. 
2.12 Telomere Repeat Amplification Protocol (TRAP) Assay 
The TRAP assay was done with TqXoTAGGG telomerase PCR ELISA (Roche) 
according to the manufacturer's instructions as follows. Briefly, the cells were 
harvested and counted using a hemocytometer. 2 x 10^ cells were transferred to a 
new eppendorf and centrifliged at 3000g for 10 minutes at 4 Supernatant was 
removed and the cell pellet was resuspended with 200|il lysis reagent and incubated 
on ice for 30 minutes. After that, the lysate was centrifuged at 16,000g for 20 
o 
minutes at 4 C. 3|LI1 of the supernatant (cell extract) was mixed with 25fil of reaction 
mixture and topped to 50|il with autoclaved double distill water. The tubes were then 
transferred to a thermo cycler and performed a combined primer elongation/ 
amplification reaction by the following protocol: Primer elongation at 25 "C for 30 
minutes，then telomerase inactivation at 9AC for 5 minutes, followed by 30 cycles of 
O o 
denaturation at 94 C for 30 seconds, annealing at 50 C for 30 seconds and 
polymerization at 72 C for 90 seconds, and at last a final extension at 72 ""c for 10 
minutes. 
After elongation and amplification, the PCR product was hybridized to a digoxigenin 
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(DIG)-labeled, telomeric repeat-specific detection probe and immobilized to a 
streptavidin-coated microplate. Firstly, 20|il of the denaturation reagent was 
transferred to each new reaction tube, and then 5|il of the PGR product was added 
and incubated at room temperature for 10 minutes. Afterwards 225 pi of hybridization 
buffer was added per tube and mixed thoroughly by vortexing. 100|il of the mixture 
was transferred per well of the precoated MP modules supplied, the wells were then 
covered with the self-adhesive cover foil and incubated at 31 C for 2 hours with 
shaking at 300rpm. After incubation, the solution was removed completely and the 
wells were washed 3 times with 250|il washing buffer. After removing all washing 
buffer, lOOfil of Anti-DIG-POD working solution was added per well and incubated 
at room temperature for 30 minutes in dark with shaking at 300rpm. Again all the 
solution was removed completely and the wells were washed with 250|il of washing 
buffer for 5 times. Then 100|il of TMB substrate solution was added per well and 
incubated at room temperature for 20 minutes with shaking at 300rpm. Without 
removing the reacted substrate, 100|il stop reagent was added to stop color 
development. By using a microplate reader, the absorbance of the samples at 450nm 
and 690nm (as a reference wavelength) was measured. 
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2.13 Cell cycle analysis 
The collected cells were washed with PBS and centrifuged at 5000 rpm at 4 � C for 5 
minutes and fixed with 70% ethanol at 4°C for 30 minutes. The cells were 
centrifliged at 5000 rpm at 4 � C for 10 minutes, washed with PBS and centrifuged 
again at 5000 rpm at 4 � C for 10 minutes to remove the fixative. Then the cells were 
re-suspended in 1ml freshly prepared PI DNA staining buffer (4|ig/ml PI, 10|ig/ml 
Rnase A in PBS) and incubated in dark at 37°C for 30 minutes. The stained cells 
were then analyzed by a flow cytometer (FACSCanto, BD Biosciences) with the 
FACSDiva software (BD Biosciences) to measure the DNA content. The cell cycle 
distribution patterns of the cells in GO/Gl, S and G2/M phases were determined by 
the MODFIT software (Verity Software House). 
2.14 MTT assay 
96-well plates were coated with gelatin. After that each clone were seeded to 6 wells 
4 
at a density of 1 x 10 cells per well. 24 hours after the medium was discarded and 
100|il of medium with Img/ml MTT were added to each well, followed by 4 hours of 
incubation at 37°C. After the incubation, I00[i\ of DMSO was added to each well to 
dissolve the formazan crystal. OD570 was then measured with OD690 as reference in 
Tecan Infinite 2000. 
54 
Chapter 2 Malerials and methods 
2.15 Statistical analysis 
The results were expressed as mean 士 SEM. Statistical significance between two 
groups of means was determined using unpaired Student's t-test. P < 0.05 was 
considered to be statistically significant. 
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CHAPTER 3 RESULTS 
3.1 mPinXlt was discovered in mESCs 
In a PGR experiment, a pair of primers flanking the coding sequence of mPinXl was 
used to amplify the mPinXl gene in undifferentiated mESCs and their differentiation 
derivatives. An additional band (-1100 bp) on top of the expected mPinXl band (999 
bp) was found (Fig.3.1). The sequence of the additional band was sequenced and 111 
additional nucleotides, when compared with the mPinXl coding sequence, was 
found. This additional l l l b p was blast-searched and was found to be located in 
Locus NT—039606.7, where the mPinXl gene is located. This l l l b p was found in 
between the two exons of the mPinXl gene. This newly discovered transcript variant 
was predicted to code for a novel protein of 170 amino acids because a stop codon 
was found in the additional nucleotides. It is named mPinXlt where stands for the 
‘truncated’ form of mPinXl. 
Both sequences were then subcloned into pTriEx4-neo plasmid so that the proteins, 
when translated, would be tagged with His-tag at the N-terminal (Fig.3.2). By 
transfecting the two plasmids into HEK cells and using western blot to probe for the 
His-tagged protein, the size of both mPinXl and mPinXlt could be deduced and 
compared. It was found that the size of His-mPinXl is around 55kDa, while the size 
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Of His-mPinXlt is around 30-35kDa. (Fig.3.3) The size of His tag sequence was 
around 8kDa, by subtracting the mass of His tag, the deduced mPinXl and mPinXlt 
sizes were around 47kDa and 22-27kDa respectively. 
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Figure 3.10 
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Figure 3.1 Gel photo showing the expression of mPinXl and mPinXlt in 
undifferentiated mESCs (imdiff. 1-3) and their Day 7+25 differentiation derivatives 
(diff. 1-3). By using a pair of primer flanking the coding sequence of mPinXl, both 
mPinXl and mPinXlt could be detected in the two types of cells. 
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Figure 3.2 The vector maps of (upper panel) pTriEx4-neo-mPinXl and (lower panel) 
pTriEx4-neo-mPinX 11. 
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Figure 3.10 
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Figure 3.3 Western blot showing the expression of His-mPinXl and His-mPinXlt 
when pTriEx4-neo-mPinXl and pTriEx4-neo-mPinX 11 plasmids were transfected 
into HEK cells�（From left) Lane 1: HEK transfected with pTriEx4-neo-mPinXl. 
Lane 2: HEK transfected with pTriEx4-neo-mPinX 11. Lane 3: HEK transfected with 
pTriEx4-neo vector only. Lane 4: Ladder. 
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3.2 mPinXl and mPinXlt were expressed at transcriptional level in the 
inspected mouse tissues 
After knowing that mPinXl and mPinXlt are expressed in mESCs and their 
derivatives (Fig.3.4 & Fig.3.5), we would like to know if they are expressed in 
normal mouse tissues. RT-qPCR was done on mPinXl and mPinXlt with 12 mouse 
tissues, undifferentiated mESCs and their differentiation derivatives. Both mPinXl 
and mPinXlt could be detected in the 12 mouse tissues investigated at transcriptional 
level. All the gene expression levels were normalized with that of Day 7+25 
differentiation derivatives. mPinXl expression was found to be higher in liver, while 
mPinXlt expressed at a higher level in testis and uterus. (n=l-2, Fig.3.4 & Fig.3.5) 
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Figure 3.4 (Upper panel) RT-PCR result showing the expression of mPinXl in 12 
mouse tissues, undifferentiated mESCs and their Day 7+25 differentiation derivatives. 
mPinXl 
transcript could be detected in all the mouse tissues and cell types 
investigated. (Lower panel) Bar chart showing the RT-qPCR result of mPinXl 
transcript expression in 12 mouse tissues, normalized with Day 7+25 differentiation 
derivatives group. P-actin was used as the loading control. mPinXl expression was 
found to be highest in liver. Values are mean 士 S.E.M. of 1-2 experiments. 
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Figure 3.5 (Upper panel) RT-PCR result showing the expression of mPinXlt in 12 
mouse tissues, undifferentiated mESCs and their Day 7+25 differentiation derivatives. 
mPinXlt 
transcript could be detected in all the mouse tissues and cell types 
investigated. (Lower panel) Bar chart showing the RT-qPCR result of mPinXlt 
transcript expression in 12 mouse tissues, normalized with Day 7+25 differentiation 
derivatives group. P-actin was used as the loading control. mPinXlt expression was 
found to be highest in testis and uterus. Values are mean 士 S.E.M. of 1-2 
experiments. 
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3.3 Expression of mPinXl and mPinXlt changed upon differentiation 
Previous studies showed that telomerase activity will decrease dramatically upon 
- 仏 ‘ 
differentiation [2’ 44, 78, 80], it is possible that the expressions of its regulators also 
change as development proceeds. To see if the expression of the two genes will 
change upon differentiation, RT-qPCR was done on undifferentiated mESCs and 
their differentiation derivatives (Day 7+25). It was found that the mRNA expression 
of mPinXl decreased (1.00 ± 0.17 Vs 0.48 士 0.06, n=7, p<0.05) while that of 
mPinXlt increased (1.00 士 0.13 Vs 1.46 士 0.16, n=7, p<0.05) upon differentiation. 
(Fig.3.6) Western blot using an in-house antibody against PinXl revealed multiple 
bands in both the undifferentiated and differentiation derivatives; 
peptide-preincubation experiment showed that bands at around 45 and 70 kDa are the 
specific bands (Fig. 3.8). The size of mPinXl matched with the predicted size, which 
is around 47kDa in both undifferentiated mESCs and its differentiation derivatives. 
The protein expression of mPinXl decreased upon differentiation (2.84 士 0.06 in 
mESCs Vs 1.00 士 0.08 in differentiation derivatives, n=7, p<0.01, Fig.3.8). This 
suggests that both of them might play a role in the mechanisms involved in/ induced 
by differentiation. 
Apart from the findings that the expressions of both genes change during 
differentiation, to see if the endogenous levels of the two genes are different at 
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particular stages, the transcript expression levels ofmPinXl and inPinXlt were also 
compared in the undifferentiated and differentiated stages. mPinXl level was much 
higher than that of mPinXlt in both the undifferentiated stage (1.00 士 0.00 for 
mPinXl Vs 0.05 士 0.01 for mPinXlt, n二7, p<0.001) and the differentiated stage 
(Day 7+25) (1.00 士 0.00 for mPinXl Vs 0.12 士 0.02 for mPinXlt, n=7, p<0.001) 
(Fig.3.7). 
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Figure 3.6 RT-qPCR results showing the gene expressions of (upper panel) mPinXl 
and (lower panel) mPinXlt in undifferentiated mESCs and their Day 7+25 
differentiation derivatives. The gene expressions were normalized with 
undifferentiated mESCs group, p-actin was used as the loading control. mPinXl 
expression decreased upon differentiation, while mPinXlt expression increased upon 
differentiation. Values are mean 士 S.E.M. of 7 experiments. *p<0.05 Vs 
undifferentiated mESCs group. 
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Figure 3.7 RT-qPCR result comparing the gene expression of mPinXl and mPinXlt 
in undifferentiated mESCs and their Day 7+25 differentiation derivatives. The gene 
expression level of mPinXlt was normalized with that of mPinXl. P-actin was used 
as the loading control. mPinXl expression was much higher than that ofmPinXl t in 
both groups of cells. Values are mean 士 S.E.M. of 7 experiments. ***p<0.001 Vs 
mPinXl. 
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Figure 3.8 (Upper panel) Western blot showing the protein expression of mPinXl in 
undifferentiated mESCs and their Day 7+25 differentiation derivatives. P-tubulin was 
used as the loading control. Pre-absorption with peptide was done to make sure the 
bands were specific. (Lower panel) Bar chart showing the mPinXl expression 
normalized with that of Day 7+25 differentiation derivative groups. The mPinXl 
level was higher in undifferentiated mESCs than in the Day 7+25 differentiation 
derivatives. Values are mean 士 S.E.M. of 3 experiments. **p<0.01 Vs Day 7+25 diff. 
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3.4 mPinXl and mPinXlt were both located in the nucleolus and the 
nucleoplasm in undifferentiated mESCs 
Previous studies showed that the hPinXl mainly resides in the nucleolus [53, 54, 68]; 
however, the subcellular localization of the mouse homolog is unknown. To 
investigate the subcellular localization ofmPinXl and mPinXlt, sub-cloning of the 
two genes into the pWPXL plasmid was performed. Transcription and translation of 
the plasmids will result in GFP fusion proteins (Fig.3.9). The constructs were then 
transfected into mESCs and examined under confocal microscope with staining of 
nucleus with PI and nucleolus with fibrillarin. mPinXl was found to mainly localize 
in the nucleolus, with some localizing in the nucleoplasm, similar to what has been 
observed for hPinXl [54] (Fig.3.10). Similarly, mPinXlt also mainly resided in the 
nucleolus, with some resided in the nucleoplasm (Fig.3.11). 
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Figure 3.10 
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Figure 3.9 The vector maps of (upper panel) pWPXL-mPinX 1 -GFP and (lower panel) 
pWPXL-mPinXlt-GFR 
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Figure 3.10 
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Figure 3.10 Sub-cellular localization of mPinXl in mESCs by confocal microscopy. 
(From left to right) The 4 diagrams in each figure represent the cells under bright 
field, green signal given by GFP tagged mPinXl, red signal given by fibrillarin 
which stained the nucleolus or red signal given by PI which stained the nucleus, and 
the merged red and green signal. Overlapping of the green and both red signals 
indicates mPinXl-GFP resided in both nucleoplasm and nucleolus. 
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Figure 3.16 
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Figure 3.11 Sub-cellular localization of mPinXlt in mESCs by confocal microscopy. 
(From left to right) The 4 diagrams in each figure represent the cells under bright 
field, green signal given by GFP tagged mPinXlt, red signal given by fibrillarin 
which stained the nucleolus or red signal given by PI which stained the nucleus, and 
the merged red and green signal. Overlapping of the green and both red signals 
indicates mPinXlt-GFP resided in both nucleoplasm and nucleolus. 
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3.5 Co-immunoprecipitation (Co-IP) of mPinXl and mPinXlt with mTERT 
Previous studies showed that hPinXl directly bind with hTERT [112]. To investigate 
if mPinXl and/or mPinXlt regulate telomerase activity using similar mechanism in 
mESCs，Co-IP of mPinXl and mTERT (or mPinXlt and mTERT) was carried out to 
see if mPinXl and/or mPinXlt interact with mTERT. pCMV-HA-mPinXl, 
pCMV-HA-mPinXlt and pCMV-Myc-mTERT were made (Fig.3.12). 
pCMV-HA-mPinXl + pCMV-Myc-mTERT, or, in another set of experiment, 
pCMV-HA-mPinXlt + pCMV-Myc-mTERT, were co-transfected into HEK cells. 
The cells were collected 48 hours after transfection and subjected to Co-IP. In both 
experiments, Myc-mTERT was pulled down by anti-Myc antibody. HA-mPinXl and 
HA-mPinXlt in the pull-down lysate were detected by anti-PinXl antibody. In the 
control experiments, Myc-mTERT was pulled down by anti-Myc antibody (Fig.3.13 
& Fig.3.14). Both HA-mPinXl and HA-mPinXlt could be found in the pull-down 
lysates and detected by the anti-PinXl antibody (Fig.3.13 & Fig.3.14). In the 
negative control, empty myc-vector was co-transfected with either 
pCMV-HA-mPinXl or pCMV-HA-mPinXlt. Using anti-Myc to pull down did not 
result in the detection of mPinXl or mPinXlt in the pull-down lysate. Altogether, the 
results suggest that both mPinXl and mPinXlt could interact with mTERT. (n=3-5, 
Fig.3.13 & Fig.3.14). 
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Figure 3.16 
Natl KasJ; Sse6387 Ehd 丨 ：日 spMI 
Bbd3 丨 BsaAl 
X CMV \ BspMI 
/ a I \ PPUM 
- I . . / / , - \..，fi| 
/ / 、 會 ⑷ 
AmpR pCMV-HA-mPinX1 湖 | I .PfiM 
I 4757 bps 1 \ % // / 
一 . . Y - / A : 
\ z 7sm ^ / BstXI 
：弹Ai 
7 ' ' . N c t l Afllir Xmal Mjnl Sapl 
Narl. KasI ： Sse8387 Ehel，） ； BspMI 日 be 丨 ： BsaAl J ^ :SnaBI 
Sspl. / CMV .BspMI •yZ , \ / PpuMI 
/ \ I V , StuI 
Seal.. / / f ^ V - ^ 
7 // ^ T...Dra„, 
A _ PCMV.HA-mPinX1t 圆 - ^ 
, HA-PinX1t I 
4271 bps I — 
- J!-
•sai • \ X HirJII Eam1105 \ = / ？_ 
\ \ / Xmal 
AIWNI ~ S a p l 
Afll  
74 




Xrrni 么々 Sfi Seal, y^ CM/ ,. EcoRI 
/ pCMV-Myc-mTERT \ 广。丨 
_ . F^hAJ 
I ^ 7136 bps a™ 〜 
\ /Y / AsuW 
Afllll \ cm 3inM/c_mTffiT^  J 
Xfralll.: ^ ^ � � 
Nofl. .. r. “ • Bel PpulO.: ： fet日I 
二: 如丨 
Figure 3.12 The vector maps of (upper panel) pCMV-HA-mPinXl, (middle panel) 
pCMV-HA-mPinXlt and (lower panel) pCMV-Myc-mTERT. 
75 
Chapter 3 Res i ills 
Figure 3.16 
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Figure 3.13 Representative blot of the Co-IP of Myc-mTERT and HA-mPinXl. 
Myc-mTERT was expressed in HEK cells and could be pulled down by anti-Myc 
antibody. (Left panel) The pull-down was specific as no specific band was detected 
in antibody negative control lane and pCMV-Myc vector lane. (Right panel) 
HA-mPinXl could be found in the pull down lysate as detected by Anti-PinXl 
antibody (as indicated by the red arrow). The interaction was specific to 
Myc-mTERT as no specific band was detected in antibody negative control lane and 
pCMV-Myc vector control lane. 
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Figure 3.16 
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Figure 3�14 Representative blot of the Co-IP of Myc-mTERT and HA-mPinXlt. 
Myc-mTERT was expressed in HEK cells and could be pulled down by anti-Myc 
antibody. (Left panel) The pull-down was specific as no specific band was detected 
in antibody negative control lane and pCMV-Myc vector lane. (Right panel) 
HA-mPinXIt could be found in the pull down lysate as detected by Anti-PinXl 
antibody (as indicated by the red arrow). The interaction was specific to 
Myc-mTERT 
as no specific band was detected in antibody negative control lane and 
pCMV-Myc vector control lane 
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3.6 Transient knockdown of mPinXl in mESCs 
To investigate the role of mPinXl in maintaining the characteristics of mESCs, 
including proliferation, viability, pluripotency and cell cycle distribution, we 
performed knockdown experiments of mPinXl by employing siRNAs against 
mPinXl. Since previous studies showed that PinXl exerts its effect mainly by 
regulating telomerase activity [54, 112], the effect of mPinXl knockdown on 
telomerase activity was also investigated. 
The knockdown of mPinXl was most significant at 24 hours after transfection (0.48 
土 0.06 Vs 1.00 士 0.00 of the scrambled control, n=4, p<0.05, Fig.3.15), with a slight 
rebound at 48 hours (0.59 ± 0.11 vs 1.00 士 0.00 of the scrambled control, n=4, 
p<0.01, Fig.3.15). On the other hand, mPinXlt was marginally knocked down at 
both time points (0.81 士 0.07 Vs 1.00 士 0.00 of the scrambled control at 24 hours, 
n=4, pO.OOl; 0.83 士 0.02 Vs 1.00 士 0.00 of the scrambled control at 48 hours, n=4, 
p<0.05, Fig.3.15). 
By western blot analysis, the protein of mPinXl was also detected to be knocked 
down by siPinXl at both 24hr and 48hr after transfection (0.74 士 0.07 Vs 1.00 士 0.00 
of the scrambled control, n=6, p<0.05 at 24 hours, 0.83 ± 0.06 Vs 1.00 ± 0.00 of the 
scrambled control, n=4, p<0.05 at 48 hours, Fig.3.16). 
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3.6.1 Knockdown of mPinXl decreased proliferation but did not change cell 
viability 
Trypan blue exclusion assay was done at 24 and 48 hours after transfection. 5X10^ 
cells were plated in both groups one day prior to transfection. At 24 hours after 
transfection, the normalized number of viable cells in siPinXl group was less than 
that of the scrambled siRNA group (0.89 士 0.02 Vs 1.00 士 0.00, n二4-5, pO.Ol , 
Fig.3.17), meaning that the cell proliferation rate was decreased with mPinXl 
knockdown. However, the effect faded out at 48 hours. On the other hand, there were 
no difference in cell viability between the two groups at both time points, showing 
that knockdown of mPinXl did not change the viability (n=4-5, Fig.3.17). 
3.6.2 Knockdown of mPinXl decreased telomerase activity 
TRAP assay was done at 24 hours and 48 hours after transfection. The telomerase 
activities of the siPinXl-transfected group were normalized to that of the scrambled 
siRNA-transfected group. siPinXl-transfected group showed a decreased telomerase 
activity at both time points (0.84 士 0.04 Vs 1.00 士 0.00 at 24 hours, n=4-5, p<0.05; 
0.87 士 0.04 Vs 1.00 士 0.00 at 48 hours, n=4-5, p<0.05, Fig.3.18), meaning that 
knockdown ofmPinXl caused a decrease in telomerase activity. The results hint that 
mPiaXl did not act as a negative telomerase regulator at this cellular context. 
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3.6.3 Knockdown of mPinXl did not change pluripotency 
Western blot analysis was done at 24 hours and 48 hours after the transfection to 
investigate if knockdown of mPinXl would affect pluripotency. Four pluripotent 
markers, Oct-4, Klf-4, Nanog and Sox-2, were chosen. p-Tubulin and H3 were used 
as the loading control. No significant change in their expressions could be detected 
after siPinXl transfection at both time points, meaning that transient knockdown of 
mPinXl did not change the pluripotent property of mESCs (n=3-4, Fig.3.19 & 
Fig.3.20). 
3.6.4 Knockdown of mPinXl did not affect cell cycle distribution 
At 24 hours after transfection, cells were subjected to the investigation of the cell 
cycle distribution by flow cytometry. No significant change on cell cycle profile was 
detected after siPinXl transfection, meaning that transient knockdown of mPinXl 
did not affect the cell cycle distribution of mESCs (n=3, Fig.3.21). 
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Figure 3.15 RT-qPCR results showing the expression of mPinXl and mPinXlt after 
mPinXl knockdown. The gene expression levels were normalized with that of 
scrambled siRNA transfected group. P-actin was used as the loading control. (Upper 
penal) The knockdown of mPinXl was most significant at 24hr after transfection to 
� 0 . 5 fold, with a slight rebound at 48hr. (Lower penal) mPinXlt was knocked down 
to -0.8 fold at both time points. Values are mean 士 S.E.M. of 4 experiments. *p<0.05, 
**p<0.01, ***p<0.001 Vs Scrambled siRNAgroup. 
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Figure 3.16 Representative western blot and bar chart showing mPinXl protein level 
after mPinXl knockdown. mPinXl protein was knocked down to �0.7-0.8 fold at 
both 24hr and 48hr after transfection. Values are mean 士 S.E.M. of 4-6 experiments. 
*p<0.05 Vs Scrambled siRNA group. 
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Figure 3.17 Trypan blue exclusion assay results after mPinXl knockdown. (Upper 
panel) At 24hr after transfection, the number of viable cells in siPinXl group was 
�lOo/o less than the scrambled siRNA group, but the effect faded out at 48hr. (Lower 
panel) There was no difference in viability between the two groups at both time 
points. Values are mean 士 S.E.M. of 4-5 experiments. **p<0.01 Vs Scrambled 
siRNA group. 
83 
Chapter 3 Res i ills 
Figure 3.16 
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Figure 3.18 TRAP assay result showing the telomerase activity after mPinXl 
knockdown. The telomerase activities were normalized with the scrambled siRNA 
transfected group. siPinXl transfected group showed �lOo/o decreased telomerase 
activity at both time points. Values are mean 士 S.E.M. of 4-5 experiments. *p<0.05 
Vs Scrambled siRNA group. 
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Figure 3.19 Representative western blot showing the expression of 4 pluripotent 
markers Oct-4, Klf-4, Sox-2 and Nanog after mPinXl knockdown. H3 and P-Tubulin 
were used as the loading controls. 
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Figure 3.20 Bar charts showing the expression of 4 pluripotent markers (A) Oct-4, (B) 
Klf-4, (C) Sox-2 and (D) Nanog after mPinXl knockdown. There was no significant 
change in their expressions after siPinXl transfection at both time points. Values are 
mean 士 S.E.M. of 3 experiments. 
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Figure 3.21 The cell cycle profile of (upper left panel) the siPinXl tranfected and 
(upper right panel) the scrambled siRNA transfected mESCs at 24hr after tranfection 
and (lower panel) the bar chart showing the % of population in each cell cycle phases. 
There was no significant change in the % of population in the three cell cycle phases 
after mPinXl knockdown. Values are mean 士 S.E.M. of 3 experiments. 
87 
Chapter 3 Results 
3.7 Transient knockdown of mPinXlt using siRNA against mPinXlt in mESCs 
In order to investigate the role of mPinXlt in mESCs, we designed 2 siRNAs 
targeting 2 different specific regions on mPinXlt and hoped to see the knock down 
effect ofmPinXlt in mESCs. However, both siRNAs failed to knockdown mPinXlt 
gene (n=3, Fig.3.22). 
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Figure 3.22 RT-qPCR results showing the expression of mPinXl and mPinXlt in 
mESCs by 2 siRNAs targeting 2 different regions on mPinXlt. The gene expression 
levels were normalized with scrambled siRNA transfected group, p-actin was used as 
the loading control. Both siRNAs failed to knock-down mPinXlt at mRNA level. 
Values are mean 士 S.E.M. of 3 experiments. 
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3.8 Transient over-expression of mPinXl and mPinXlt in mESCs 
Both mPinXl and mPinXlt were subcloned into pCMV-Myc vector, and then the 
Myc-mPinXl and Myc-mPinXlt were further subcloned into the pWPI vector (Fig. 
3.23). pWPI vector contains the EF-la promoter which can allow genes under its 
control to be robustly expressed in mESCs [95]. The resultant pWPI-Myc-mPinXl 
(namely pWPI-mPinXl in the following parts) and pWPI-Myc-rnPinXlt (namely 
pWPI-mPinXlt in the following parts) plasmids were then transfected into mESCs 
followed by proliferation assay, viability assay, TRAP and western blot analysis of 
the pluripotent markers. 
In pWPI-mPinX 1 -transfected group, over-expression of mPinXl was most 
significant at 24 hours after transfection where mPinXl expression was increased to 
24.16 ± 4.14 fold when comp-red with that of empty vector-transfected group (n=4, 
p<0.05, Fig.3.24). At 48 hours and 72 hours after transfection, the over-expression 
effect was diminished to 3.65 士 0.32 (n=4, pO.Ol, Fig.3.24) and 2.25 ±0.16 fold of 
increase, respectively (n=3, p<0.01, Fig.3.24). The expression ofmPinXlt gene was 
not affected when mPinXl was over-expressed at both 24hr, 48hr and 72hr (n=3-6, 
Fig.3.24). 
On the other hand, in pWPI-mPinX 11-transfected group, over-expression of the 
mPinXlt was most significant at 24 hours after transfection where mPinXlt 
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expression was increased to 657.07 ±38.17 fold when compared with that of empty 
vector-transfected group (n=4, p<0.001, Fig.3.25). At 48 hours and 72 hours after 
transfection, the over-expression effect was diminished to 4 3 . 9 7 士 1 0 . 7 2 and 1 1 . 8 1 士 
3.17 (n=3, Fig.3.25) fold of increase, respectively. Interestingly, when mPinXlt was 
over-expressed, the expression of mPinXl also changed significantly, with 11.77 士 
0.77 fold of increase at 24 hours (n二4, p<0.001, Fig.3.25). The increase was not 
significant at 48 and 72 hours (n=3, Fig.3.25). This increase suggested a possible 
regulatory role of mPinXlt on mPinXl gene. 
By western blotting, the overexpression of mPinXl and mPinXlt could be detected 
at protein level at 24 hours after transfection, as shown by the appearance of the 
additional band of Myc-mPinXl and Myc-mPinXlt in the respective over-expression 
groups. However, at 48 hours after transfection, only the Myc-mPinXl could be 
detected (n=2, Fig.3.26). 
3.8.1 Over-expression of mPinXl and mPinXlt decreased cell proliferation but 
did not affect cell viability 
Trypan blue exclusion assay was done at 24, 48 and 72 hours after transfection. 
5X104 cells were plated one day prior to transfection. For pWPI-mPinX 1 -transfected 
group, the normalized number of viable cells was less than that of the empty vector 
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group at all time points (0.88 土 0.02 Vs 1.00 土 0.00 at 24 hours, n=5, p<0.01; 0.87 土 
0.03 Vs 1.00 ± 0.00 at 48 hours, n=6, p<0.01; 0.86 士 0.02 Vs 1.00 土 0.00 at 72 hours, 
n二3, p<0.05, Fig.3.27), meaning that the cell proliferation rate was decreased with 
mPinXl over-expression. For pWPI-mPinX 1 t-transfected group, the number of 
viable cells was also significantly less than that of the empty vector group at 24 hours 
and 72 hours after transfection (0.87±0.04 Vs 1±0.00 at 24 hours, n=5, p<0.05; 
0.89±0.02 Vs 1±0.00 at 72 hours, n=3, p<0.05, Fig.3.27), meaning that mPinXlt 
over-expression decreased the proliferation of mESCs. There was no significant 
difference in cell viability between the two groups and the empty vector group at all 
time points, suggesting that the over-expression of mPinXl and mPinXlt did not 
change the cell viability (n=5-6, Fig.3.27). 
3.8.2 Over-expression of mPinXl increased telomerase activity 
TRAP assay was done at 24，48 and 72 hours after transfection. The telomerase 
activities of the overexpression group were normalized to that of the empty vector 
group, pWPI-mPinX 1 -transfected group showed an increased telomerase activity 24 
hours after transfection when compared to that of the empty vector-transfected group 
(1.10 士 0.03 Vs 1.00 士 0.00 at 24 hours, n二5，p<0.05, Fig.3.28), suggesting that 
over-expression ofmPinXl caused an increase in telomerase activity. The results hint 
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that mPinXl did not act as a negative telomerase regulator at this cellular context. On 
the other hand, over-expression of mPinXlt did not change the telomerase activity 
(n=3-5, Fig.3.28). 
3.8.3 Over-expression of mPinXl and mPinXlt did not affect pluripotency 
Western blot was done at 24hr and 48hr after transfection to investigate if 
over-expression of mPinXl and mPinXlt would affect pluripotency. Pluripotent 
markers Oct-4, Klf-4, Sox-2 and Nanog were chosen; P-Tubulin was used as the 
loading control. From the results, there was no significant change in their expressions 
after pWPI-mPinXl and pWPI-mPinXlt transfection at all time points, meaning that 
over-expression of both genes did not change the pluripotent property of the cells 
(n=3,Fig.3.29&Fig.3.30). 
3.8.4 Over-expression of mPinXl and mPinXlt did not affect cell cycle 
distribution 
At 24 hours after transfection, cells were subjected to flow cytometry to investigate 
the cell cycle distribution. No significant change was detected after pWPI-mPinXl or 
pWPI-mPinXlt transfection, meaning that transient over-expression of mPinXl or 
mPinXlt did not affect the cell cycle progression of mESCs (n=2-3, Fig.3.31). 
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Figure 3.23 The vector maps of (upper panel) pWPI-Myc-mPinXl and (lower panel) 
pWPI-Myc-mPinXlt. 
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Figure 3.24 RT-qPCR results showing the expression of (upper panel) mPinXl and 
(lower panel) mPinXlt of pWPI-mPinXl and control pWPI only group. The gene 
expressions were normalized with that of empty vector group, p-actin was used as 
the loading control. (Upper panel) The over-expression of mPinXl was most 
significant at 24hr after transfection where mPinXl expression was increased for -20 
fold. At 48hr and 72hr the effect was diminished to � 2 - 3 fold of increase. (Lower 
panel) The expression of mPinXlt gene did not change significantly during the 
process. Values are mean 士 S.E.M. of 3-6 experiments. *p<0.05, **p<0.01 Vs 
pWPI-only group. 
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Figure 3.25 RT-qPCR results showing the expression of (upper panel) mPinXlt and 
(lower panel) mPinXl of pWPI-mPinXlt and control pWPI only group. The gene 
expression levels were normalized with that of control group, p-actin was used as the 
loading control. (Upper panel) The over-experssion ofmPinXlt was most significant 
at 24hr after transfection where mPinXlt expression was increased for around 600 
fold. At 48hr and 72hr, the eitect was diminished. (Lower panel) The expressions of mPinXl gene also increased significantly to around 10 fold at 24hr. Values are mean 士 S.E.M. of 3-6 expe iments. ***p<0.001 Vs pWPI-only group. 
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Figure 3.26 Representative western blot of mPinXl and mPinXlt at protein level of 
pWPI-mPinXl, pWPI-mPinXlt and pWPI-only group. H3 was used as the loading 
control. The additional Myc-mPinXl band (upper red arrow) and Myc-mPinXIt 
band (lower red arrow) could be detected at 24hr after transfection of pWPI-mPinXl 
and pWPl-mPinXlt respectively, but only the Myc-mPinXl could be detected at 
48hr after transfection of pWPT-mPinXl. 
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Figure 3.27 Trypan blue exclusion assay results at 24hr, 48hr and 72hr after 
transfection. (Upper panel) For pWPI-mPinXl group, the number of viable cells was 
� 1 0 % less than that of the empty vector group at all time points. For pWPI-mPinXlt 
group, the number of viable cells was also shown �lOo/o decrease compared to that of 
the empty vector group at 24hr and 72hr after transfection. (Lower panel) There was 
no significant difference in % of viability between the two groups and that of the 
empty vector group at all time points. Values are mean 士 S.E.M. of 3-6 experiments. 
*p<0.05, **p<0.01 Vs pWPI-only group. 
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Figure 3.28 TRAP assay result showing the telomerase activity at 24hr, 48hr and 
72hr after transfection. The telomerase activities were normalized with that of the 
pWPI empty vector group. pWPI-mPinXl group showed a � 1 0 % increased 
telomerase activity at 24hr. Values are mean 士 S.E.M. of 3-5 experiments. *p<0.05 
Vs pWPI-only group. 
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Figure 3.29 Representative western blot results showing the expression of 4 
pluripotent markers Oct-4, Klf-4, Sox-2 and Nanog at 24hr and 48hr after 
transfection of pWPI-mPinX 1, pWPI-mPinXlt, pWPI-only. p-Tubulin was used as 
the loading control. 
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Figure 3.30 Bar charts showing the expression levels of 4 pluripotent markers (A) 
Oct-4, (B) Klf-4, (C) Sox-2 and (D) Nanog at 24hr and 48hr after transfection of 
pWPI-mPinXl, pWPI-mPinXlt and pWPI-only. There was no significant change in 
their expression levels at both time points. Values are mean 士 S.E.M. of 3 
experiments. 
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Figure 3.31 The cell cycle profiles of (upper left panel) the pWPI-mPinXl 
transfected, (upper right panel) pWPI-mPinXlt transfected and (middle panel) 
pWPI-only transfected mESCs at 24hr after transfection and (lower panel) the bar 
chart showing the % of population in each cell cycle phases. There was no significant 
change in the % of population in the three cell cycle phases after pWPI-mPinXl and 
pWPI-mPinXlt transfection. Values are mean 士 S.E.M. of 2-3 experiments. 
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3.9 Stable over-expression and knockdown of mPinXl and mPinXlt in mESCs 
Stable over-expression and knockdown of the two genes were done to investigate if 
changing the expression of these 2 genes in the long-run would exert any cellular 
effect in a way similar to (yet with amplified effect) the results observed in transient 
experiments. The three plasmids used in the previous transient over-expression 
experiments, namely the pWPI-mPinXl, pWPI-mPinXlt and pWPI vectors, were 
used for the stable over-expression experiment. pLVTHM-shPinXl and the 
pLVTHM-shScrambled plasmids were also generated (Fig.3.32). All the plasmids 
were introduced into mESCs by lenti-viral infection and stable clones were selected 
(as shown in Chapter 2 Materials and Methods). For mPinXl over-expression group, 
the four clones selected were named as Pwpi-PinXl Cl 'A, C13, CIB and Cl 'B. For 
mPinXlt over-expression group, the three selected were named as Pwpi-PinXlt C3A, 
C8B and C9A. For over-expression control group, the three clones selected were 
named as Pwpi-only CIO, CI 1, and C12'. (Fig.3.33) For mPinXl knockdown group, 
the three clones were named as shPinXl C5, CIB and Cl 'B. For the knockdown 
control group, the three clones were named as shScrambled C3, C7 and C8. (Fig.3.34) 
The selected clones were established to stable cell lines and the effects on 
proliferation, viability, telomerase activity, pluripotency were examined. 
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Figure 3.32 Vector maps of (upper panel) pLVTHM-shPinXl and (lower panel) 
pLVTHM-shScrambled plasmids. 
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Figure 3.33 Appearance of the established mPinXl, mPinXlt over-expression and 
control mESC cell lines. 3 stable cell lines were established for control group 
(Pwpi-only, CIO', CI 1，, C12') and mPinXIt over-expression group (Pwpi-PinXlt C3, 
C7 and C8). 4 stable cells lines were established for mPinXl over-expression group 
(Pwpi-PinXl Cl'A, CIB, Cl 'B and C13). 
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Figure 3.34 Appearance of the established mPinXl knockdown and control mESC 
cell lines. 3 stable cells lines were established for mPinXl knockdown group 
(shPinXl CIB, Cl 'B and C5) and scrambled shRNA control group (shScrambled C3, 
C7 and C8). 
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3.9.1 Expression of mPinXl and mPinXlt at mRNA and protein level in all 
over-expression stable cell lines 
The level of mPinXl and mPinXlt of the over-expression cell lines at both mRNA 
and protein levels were examined by RT-qPCR and western blot analysis. For the 
mPinXl over-expression cell lines Pwpi-PinXl CI 'A, C13, CIB and C1，B, the 
mPinXl mRNA levels were elevated to 19.02-, 23.48-, 20.03- and 18.99-fold, 
respectively, when compared to that of the average of the control cell lines Pwpi-only 
CIO’，Cll, and C12' (Fig.3.35). The mPinXl gene was also up-regulated at protein 
level for 2.24-, 1.70-, 1.89-, 1.66-fold, respectively, when compared to that of the 
average of control cell lines, with the appearance of the myc-mPinXl band on top of 
the endogenous mPinXl band (Fig.3.36). Over-expression of mPinXl in these cell 
line groups did not affect the expression of mPinXlt at mRNA level. The expression 
of mPinXlt in these groups were 1.26-, 1.43-, 1.02- and 1.04-fold, respectively, 
when compared to that of the control groups (Fig.3.35). 
For the mPinXlt over-expression cell lines Pwpi-PinXlt C3A, C9A and C8B, the 
level of mPinXlt gene at mRNA levels were greatly up-regulated for 438.18-, 
210.89-, 290.70-fold, respectively, when compared to that of the average of the 
control cell lines Pwpi-only CIO,, C l l , and C12, (Fig.3.35). The gene was also 
up-regulated at protein level with the appearance of a band between 20kDa and 
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30kDa, which is the expected size of the myc-mPinXlt protein and this additional 
band disappeared when the anti-PinXl anti-body was pre-incubated with the peptide 
(Fig.3.37). Its level was increased for 2.68-, 4.55-, 1.57-fold, respectively, when 
compared to that of the control groups (Fig.3.37). Interestingly, the level of mPinXl 
was also up-regulated at mRNA level in these groups for 9.08-, 4.47-, 4.85-fold, 
respectively, when compared to the average of control groups (Fig.3.35). However, 
this increase could not be seen at protein level (Fig.3.37). 
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Figure 3.35 RT-qPCR results showing the mPinXl and mPinXlt mRNA expression 
level of the stable cell lines. All the gene expression levels were normalized to the 
average of that of the control (Pwpi only) cell lines. P-Actin was used as a loading 
control. (Upper panel) mPinXl expression was increased for � 2 0 fold in all the 
mPinXl over-expression (Pwpi-PinXl) cell lines and increased for -4-10 fold in all 
the mPinXlt over-expression (Pwpi-PinXlt) cell lines respectively. (Lower panel) 
mPinXlt expression was not affected in mPinXl over-expression cell lines, but 
increased for �200-450 fold in the mPinXlt over-expression cell lines. 
110 
Chapter 3 Res i ills 
Figure 3.16 
Pwpi-PinXl Pwpi-Only 
I II 1 
C1，A C13C1BC1，B C10'C11' C12 
# 
V H % 、 一 — T 一 r 一 一 ， " . ‘ … . . ‘ • : ' 朴 ‘ 。 … “ “ ― 5 0 
� I � I HHillf 會 •^料mrnf^ 




H 3 ..nupp _峰,;、. H p H .mmm W m 
O 2.5-1 
'55 „ „ 
w i m i 
£ 2.0-
litm 
、。•〜。、公 o - ^ � � ‘ 
Figure 3.36 Western blot and bar chart showing the mPinXl protein expression level 
of the mPinXl over-expression (Pwpi-PinXl) stable cell lines. All the protein 
expressions were normalized to the average of the control (Pwpi only) cell lines; H3 
was used as a loading control. (Upper panel) An additional myc-mPinXl band (as 
indicated by the red arrow) could be seen for all mPinXl over-expression stable cell 
lines. (Lower panel) mPinXl expression was increased for �1.8-2.5 fold in all the 
mPinXl over-expression cell lines. 
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Figure 3.37 Western blot and bar charts showing the mPinXl and mPinXlt protein 
expression level of the mPinXlt over-expression (Pwpi-PinXlt) stable cell lines. All 
the protein expressions were normalized to the average of that of the control 
(Pwpi-only) cell lines; p-Tubulin was used as a loading control. (Upper panel) An 
additional myc-mPinXlt band (as indicated by the lower red arrow) could be seen for 
all mPinXlt over-expression stable cell lines. The additional band disappeared when 
the anti-PinXl antibody was pre-incubated with peptide. On the other hand, there is 
no observable change in the expression of mPinXl (as indicated by the upper red 
arrow). (Lower left panel) mPinXlt expression was increased for �1.5-4.6 fold in all 
the mPinXlt over-expression cell lines. (Lower right panel) There was no significant 
change in the mPinXl expression level in the mPinXlt over-expression cell lines. 
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3.9.2 Expression of mPinXl and mPinXlt at mRNA and protein level in 
mPinXl knockdown stable cell lines 
The expression of both mPinXl and mPinXlt gene were examined in the mPinXl 
stable knockdown cell lines. For mPinXl, the gene was successfully knocked down 
at both mRNA and protein levels. The mPinXl mRNA level for shPinXl CIB, C1,B 
and C5 was diminished to 0.63-, 0.17- and 0.16- fold respectively, when compared to 
that of the average of the control cell lines shScrambled C3, C7 and C8 (Fig.3.38). At 
protein level, the expression of mPinXl was also diminished to 0.51-, 0.48- and 
0.49-fold when compared to the average of that of the control cell lines (Fig.3.39). 
For mPinXlt gene, it also showed a slight knockdown in the shPinXl cell lines to 
0.81-, 0.65- and 0.63- fold respectively when compared to control cell lines. 
(Fig.3.38). The degree of knockdown of mPinXlt was much lower than that of 
mPinXl. 
113 





^ 『,••棚 . J rp^r^ p丨丨•_•，— 
1 像 � A 
1 i m ？》 
1 0.5- $MM � 
1 _ _ 4 � �‘�Mm*i— 
1.5-| 
c 
铅10 r r r n n 参 
i 戮 
i _ 黎 r ^ ^ 
I _ _ p 終 
i « 
� i i , i _ a iiiii _ jg" 
Figure 3.38 RT-qPCR result showing the mPinXl and mPinXlt mRNA expression 
level of the mPinXl knockdown stable cell lines. All the gene expression levels were 
normalized to the average of that of the control (shScrambled) cell lines. P-Actin was 
used as a loading control. (Upper panel) mPinXl expression was down-regulated to 
�0.1-0.6 fold in all the mPinXl knockdown (shPinXl) cell lines. (Lower panel) 
mPinXlt 
expression had a minor effect of down-regulation to �0.6-0.8 fold in all the 
mPinXl knockdown cell lines. 
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Figure 3.39 Western blot and bar chart showing the mPinXl protein expression level 
of the mPinXl knockdown (shPinXl) stable cell lines. All the protein expressions 
were normalized to the average of the control (shScrambled) cell lines; P-Tubulin 
was used as a loading control. mPinXl expression was decreased to � 0 . 5 fold in all 
the mPinXl knockdown cell lines. 
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3.9.3 Proliferation of all stable cell lines 
To study the long term effect on cell proliferation, the stable cell lines were kept on 
being passaged for 38-39 passages starting from the day of their establishment. The 
number of cells was counted by trypan blue exclusion assays every time when the 
cells were passaged. At passages � 1 0 , � 2 0 and -30, MTT assay was also done to 
examine the proliferation rate of the cells. 
For the stable cell lines, both over-expression of mPinXl or mPinXlt, and the 
knock-down ofmPinXl did not cause a significant change in cell proliferation in the 
long run as determined by trypan blue exclusion assays (Fig.3.40 & Fig.3.41) The 
MTT assay results also showed that the proliferation rate of the stable 
over-expression/ knockdown cell lines were similar to that of the control cell lines at 
all the passages examined (n=l-2, Fig.3.42 and Fig.3.43). All these results showed 
that, unlike transient over-expression or knockdown, stable over-expression or 
knockdown of the genes did not cause any significant change in cell proliferation in 
the long term. 
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Figure 3.40 Proliferation curve of 39 passages of mPinXl over-expression 
(Pwpi-PinXl), mPinXIt over-expression (Pwpi-PinXlt) and control (Pwpi only) cell 
lines. The graph was plotted with Log2 (total number of cells) against the passage 
number. There was no significant difference in the rate of proliferation between the 
cell lines within the 39 passages. 
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Figure 3.41 Proliferation curve of 38 passages of mPinXl knockdown (shPinXl) and 
control (shScrambled) cell lines. The graph was plotted with Log2 (Total number of 
cells) against the passage number. There was no significant difference in the rate of 
proliferation between the cell lines within the 38 passages. 
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Figure 3.42 MTT result of niPinXl over-expression (Pwpi-PinXl), mPinXlt 
over-expression (Pwpi-PinXlt) and control (Pwpi-only) cell lines at (A) passages 
� 1 0 , ( B ) � 2 0 and (C) -30. The MTT absorbance was normalized to the average of 
that of the control cell lines. There was no significant difference in the MTT 
absorbance between the cell lines in all these passages. For passage � 1 0 , values are 
mean 士 S.E.M. of 3 experiments; for passage � 2 0 , values are from 1 experiment; for 
passage � 3 0 , mean 士 S.E.M. of 2 experiments. 
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Figure 3.43 MTT result of mPinXl knockdown (shPinXl) and control (shScrambed) 
cell lines at (A) passages � 1 0 , ( B ) � 2 0 and ( C ) � 3 0 . The MTT absorbance was 
normalized to the average of control cell lines. There was no significant difference in 
the rate of proliferation between the cell lines in all these passages. For passage � 1 0 , 
values are mean 士 S.E.M. of 2 experiments; for passage -20 and passage � 3 0 , values 
are from 1 experiment. 
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3.9.4 Telomerease activity of all stable cell lines 
TRAP assay was done to examine the telomerase activity of the stable cell lines. The 
results showed that for both the over-expression and the knock-down cell lines, there 
was no significant change of the telomerase activity (n=l-4, Fig.3.44). This is 
different from the transient over-expression and knock-down results, in which the 
telomerase activity was affected by the mPinXl expression. 
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Figure 3.44 TRAP assay result of all the stable cell lines. For mPinXl 
over-expression (Pwpi-PinXl), mPinXlt over-expression (Pwpi-PinXlt) stable cell 
lines, the telomerase activity was normalized to the average of control (Pwpi-only) 
cell lines. (Upper panel) For mPinXl knockdown (shPinXl) cell lines, the 
telomerase activity were normalized to the average of control (shScrambled) cell 
lines. (Lower panel) There was no significant difference in the telomerase activity of 
all the stable cell lines. For over-expression groups, the values mean 士 S.E.M. of 1-2 
experiments. For knockdown groups, the values mean 士 S.E.M. of 4 experiments. 
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3.9.5 Cell cycle distribution of all stable cell lines 
Flow cytometry was done to study the cell cycle distribution of the stable cell lines. 
All the groups of cells were collected at P29 for PI staining followed by flow 
cytometry. The results showed that the cell cycle distribution of all the cell lines were 
similar, with -60% of cells in S phase and �20O/o f cells in Gq/G, phase and S phase 
(n=l, Fig.3.45, Fig.3.46 & Fig.3.47). Since only one trial was done, more 
independent experiments are needed to confirm the results in the future. 
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Figure 3.45 The cell cycle profiles of the mPinXl over-expression (Pwpi-PinXl), 
mPinXlt over-expression (Pwpi-PinXlt) and control (Pwpi-only) cell lines. 
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Figure 3.46 The cell cycle profiles of the mPinXl knockdown (shPinXl), and control 
(shScrambled) cell lines. 
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Percentage Pwpi-mPinXl Pwpi-mPinXlt Pwpi-only 
(%) _ _ _ _ _ _ _ 
CPA C13 CIB Cl 'B C3A C9A C8B CIO' C l l ' CIV 
GO/GI 16.80 18.07 17.97 17.37 19.28 17.91 16.42 16.48 18.33 16.68 
S 65.58 61.14 67.24 64.96 62.46 63.63 63.21 64.22 63.32 60.30 
G2/M 17.62 20.78 14.79 17.67 18.26 18.45 20.37 19.31 18.36 23.02 
Percentage shPinXl shScrambled 
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Figure 3 .47 (Upper panel) The percentage of the Gq /G i , S, and G2/M phase 
populations of mPinXl over-expression (Pwpi-PinXl), mPinXlt over-expression 
(Pwpi-PinXlt) and its control (Pwpi-only) cell line. (Lower panel) The percentage of 
the Go/Gi, S, and G2/M phase populations of mPinXl knockdown (shPinXl) and its 
control (shScrambled) cell lines. There was no significant change of cell cycle 
distribution between all groups. 
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3.9.6 Pluripotency of all stable cell lines 
Western blot was done for the stable cell lines on pluripotent markers to see if there 
was a change in pluripotency upon altering the expression of the mPinXl and 
mPinXlt. Three pluripotent markers Oct-4, Klf-4, and Sox-2 were chosen. p-Tubulin 
were used as the loading control. Preliminary data showed that there was no obvious 
and consistent change in the expression of pluripotent markers in different groups. 
The inconsistent change in the expressions of pluripotent markers in different clones 
of the same group might be caused by the effect of random insertion of the 
exogenous gene in the genome. Since only one trial was done, in the future, more 
independent experiments are needed to confirm the results (Fig.3.48 & Fig.3.49). 
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Figure 3.48 Western blots showing the expression of pluripotent markers Sox-2 and 
Klf-4 in mPinXl over-expressed (Pwpi-PinXl), mPinXlt over-expressed 
(Pwpi-PinXlt) and the control (Pwpi only) cell lines. p-Tubulin was used as the 
loading control. 
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Figure 3.49 Western blot showing the expression of pluripotent markers Sox-2, Klf-4 
and Oct-4 in mPinXl knockdown (shPinXl) and the control (shScrambled) cell lines. 
P-Tubuiin was used as the loading control. 
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3.9.7 Differentiation of the stable cell lines 
To study the role of mPinXl and mPinXlt in differentiation process, two clones from 
each group of stable cell line were chosen for differentiation by hanging-drop method. 
The clones chosen were C l l ’ and CI2，for Pwpi-only, CI，A, CI3 for Pwpi-PinXl， 
C3A and C9A for Pwpi-PinXlt, C l 'B and C5 for shPinXl and C7 and C8 for 
shScrambled) 
3.9.7.1 Size of EBs formed from stable cell lines at Day 7 
At Day 7 of differentiation, the size of EBs formed was measured. For each group, 
around 40-60 EBs were measured from each stable cell line. Both over-expression of 
mPinXl or mPinXlt, and the knock-down of mPinXl did not cause a significant 
change in the size of EBs formed, they all had a diameter of around 300)im (n=2, 
Fig.3.50 & Fig.3.51). All the EBs still got green fluorescent signals, meaning that the 
exogenous mPinXl gene, mPinXlt gene and sliPinXl were still robustly expressed 
after differentiation (Fig.3.50). 
3.9.7.2 Beating curves of the stable cell lines derived EBs 
At Day 7 of differentiation, 24 EBs from each group were attached onto 24-well 
plates. From Day 7+1 to Day 7+12, the EBs were examined under microscope 
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everyday to count the number of beating EBs. 
For the over-expression groups, Pwpi-only control group and mPinXl 
over-expression group started to beat at Day 7+4, while for Pwpi-mPinXlt showed a 
trend of delayed onset of beating, which started at Day 7+5. For Pwpi-only control 
group and mPinXlt over-expression group, all clones reached maximum beating at 
around Day 7+10. For mPinXl over-expression group, both clones reached 100% 
beating at Day 7+7, showing a trend of earlier time of reaching of maximum beating. 
All groups reached percentage of beating EBs of above 95% (n=2, Fig.3.52). 
For the knock-down groups, all the EBs started to beat at around Day 7+4 and 
reached a maximum beating at around Day 7+10. For the two clones in shScrambled 
group, C7 reached a maximum of 98% beating, while C8 reached a maximum of 
100% beating. For the two clones in shPinXl group, C l 'B reached a maximum of 
770/0 beating, while C8 reached a maximum of 87% beating. Knockdown of mPinXl 
showed a trend of decreased maximum percentage of beating EBs formed (n=2, 
Fig.3.53). 
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Figure 3.16 
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Bright field Green fluorescence 
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Figure 3.50 Representative photos showing the size ofEBs from each cell line at Day 
7 after differentiation at bright field and green florescence view. 
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Figure 3.51 Bar chart showing the size of EBs from each cell line at Day 7 after 
differentiation. The sizes of EBs of all groups were around 300|im. Values are mean 
士 S.E.M. of 2 experiments. 
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Figure 3.16 
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Figure 3.52 (Upper panel) Beating curve and (lower panel) cumulative beating curve 
of mPinXl over-expression (Pwpi-PinXl), mPinXlt over-expression (Pwpi-PinXlt) 
and control (Pwpi only) cell lines. Pwpi-only control group and mPinXl 
over-expression group started to beat at Day 7+4’ while for Pwpi-mPinXlt the 
beating started at Day 7+5. For control group and mPinXlt over-expression group, 
all clones reached a maximum beating at around Day 7+10. For mPinXl 
over-expression group, both clones reached 100% beating at Day 7+7, which was 
earlier than that of control. All groups reached percentage of beating EBs of above 
95%. 
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Figure 3.53 (Upper panel) Beating curve and (lower panel) cumulative beating curve 
of mPinXl knockdown (shPinXl) stable cell lines and control (shScrambed) cell 
lines. All the EBs started to beat at around Day 7+4 and reached a maximum 
percentage of beating at around Day 7+10. For the two clones in shScrambled group, 
C7 reached a maximum of 98% beating, while C8 reached a maximum of 100% 
beating. For the two clones in shPinXl group, Cl 'B reached a maximum of 77% 
beating, while C8 reached a maximum of 87% beating. Knockdown of mPinXl 
showed a trend of decrease in the maximum percentage of beating EBs formed. 
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CHAPTER FOUR DTSCTJSSTONS 
Embryonic stem cells are known to have a high telomerase activity. This high 
activity is involved in sustaining the indefinite proliferation ability [8, 56], 
differentiation process [6] and stress resistance [48]. On the other hand, previous 
studies showed that human PinXl is a telomerase inhibitor [112]. In this project, the 
effect of mPinXl, and its novel splice variant mPinXlt, on the characteristics of 
mESCs were studied. Transient and stable over-expression and knockdown of 
mPinXl and mPinXlt were performed in mESCs; their influences on the telomerase 
activity, mESC proliferation, viability, cell cycle progression, pluripotency and 
differentiation ability were examined. 
4.1 mPinXlt gene was detected in mESCs 
mPinXlt transcript, which is a possible splice variant of mPinXl, was detected in 
mESCs and their differentiation derivatives. It contains the mPinXl gene sequence 
with exception of the additional 111 nucleotides in between two mPinXl exons. The 
111 additional nucleotides was found in Locus NT—039606.7 in the mouse genome 
where the PinXl gene was coded for. Since the template used for the PCR 
experiment was made by reverse transcription using Poly-T as primer, it is very 
likely that the mPinXlt transcript is a functional mRNA with poly-A tail. Since a 
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Stop codon is present in the additional sequence, the predicted polypeptide chain 
encoded by mPinXlt transcript is consisted of the N-terminal but not the C-terminal 
of mPinXl. Consistently, western blot result showed that the exogenously expressed 
His-mPinXlt gene encodes for a polypeptide with a size of around 30-35 kDa; given 
the His tag is of a predicted size of 8kDa, the mPinXlt is therefore of a size of 
around 22-27 kDa, which is around half of the size of mPinXl protein (47 kDa). 
Since many splice variants were shown to be involved in the regulation of the gene 
or in their related functions, it would be necessary also to find out if mPinXlt would 
regulate mPinXl gene or whether it would also regulate the telomerase activity in 
mESCs. Besides, mPinXlt would provide a good opportunity to understand the 
cellular function of the N-terminal of mPinXl. Northern blot analysis would be done 
in the future to further confirm the presence of the full transcript of mPinXlt in 
mESCs. 
4.2 Presence of mPinXl and mPinXlt in mouse tissues, mESCs and their 
differentiation derivatives 
hPinXl expression was found to be decreased in a variety of human cancers [41, 51]. 
PinXl heterozygous knockout mice also showed an increased frequency of 
developing tumor [111]. In this study, routine PCR and RT-qPCR results showed that 
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both mPinXl and mPinXlt gene were expressed in various mouse tissues, mESCs 
and their differentiation derivatives. This is in line with the studies of other PinXl 
homologs, which were found to be ubiquitously expressed in various normal tissues 
in different species [51, 52, 68, 84]. Since the expression of telomerase in normal 
somatic cells is very low or not detectable, the presence of PinXl in normal tissues 
hints that PinXl may be essential for maintaining other cellular functions. Previous 
studies have shown that yeast PinXl is crucial for pre-ribosomal RNA processing 
and small nucleolar RNA maturation [36]. In addition, hPinXl was also found to be 
involved in chromosome segregation and congression during mitosis [50, 108], yet 
the exact role of PinXl in somatic cells still awaits to be explored. 
4.3 Differences in expression of mPinXl and mPinXlt in undifferentiated 
mESCs and their differentiation derivatives 
RT-qPCR results showed that the expression of mPinXl was higher in 
undifferentiated mESCs than their differentiation derivatives, while for mPinXlt, the 
expression pattern was opposite. Western blot results also demonstrated a consistent 
change of mPinXl protein expression during differentiation. However, the 
endogenous mPinXlt protein could not be detected in both undifferentiated mESCs 
and its differentiation derivatives, which might due to the low expression level, as its 
139 
Chapter 4 Discussions 
mRNA expression was much lower (around 10-20 fold) than that of mPinXl gene. 
Switching expression level of splice variants of some genes was found to associate 
with stem cell differentiation and pluripotency [77, 105]; it is speculated that a 
change in expression of mPiiiXl and its splice variant mPinXlt might also take part 
in these processes in mESCs. A decrease of expression of mPinXl and increase of 
expression of mPinXlt as mESCs differentiate hint that the splice variants might be 
involved in the differentiation process of mESCs. 
Many studies have shown that telomerase activity decreased during differentiation, 
this might be due to the fact that differentiation causes the cells to exit from the cell 
cycle; since telomerase activity is positively related to the proliferation status, 
differentiated cells which have a lower proliferative capacity would have a lower 
telomerase activity. On the other hand, mechanisms controlling differentiation may 
down-regulate telomerase activity [6, 74, 76]. As a telomerase regulator, expression 
of mPinXl/ mPinXlt might change during differentiation in accordance to the 
down-regulation of the telomerase activity. Alternatively, the change in expression of 
mPinXl/mPinXlt could also be attributed to their involvement in differentiation [85 . 
A recent finding showed that during Xenopus embryogenesis, expression level of 
TRFl and PinXl mRNA were constant at stages 8 to 10 and then decreased 
afterwards, suggesting that PinXl might be involved in embryonic development [91. 
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Consistently, the mRNA expression of mPinXl was also shown to decrease as 
differentiation occurs. Moreover, as telomere length is known to decrease upon 
differentiation [109], it is also imaginable that the need and hence expression level of 
TRFl (being a telomeric protein), and PinXl (being an interacting protein of TRFl) 
decrease together with telomere length upon differentiation. 
From the western blot results, the band located at around 70kDa is possibly a 
post-translationally modified form of mPinXl, as it also disappeared upon peptide 
pre-incubation and the expected size of mPinXl is around 47kDa. This modified 
氧 . ‘ 
form was up-regulated upon differentiation, hinting that post-translation modification 
of mPinXl might be associated with differentiation process of mESCs. In the future, 
we would investigate this possibility by identifying the type of post-translational 
modification, followed by blocking this modification to see if there is any effect on 
the differentiation of mESCs. 
4.4 mPinXl and mPinXlt are pre-dominantly localized in the nucleolus 
mPinXl pre-dominantly localized in the nucleolus, with some located inside the 
nucleus, similar to the location of other homologs [16, 36, 68, 84]. Being in the 
nucleolus, mPinXl might be involved in some RNA processing activities. mPinXl 
possesses the G-patch domain at the N-terminus, which is known to be conserved for 
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RNA processing proteins in eukaryotes [5]. Indeed, the yeast homolog of PinXl was 
shown to be involved in rRNA processing and small nucleolar RNA maturation [36 . 
Besides, it is possible for mPinXl to interact with TERT inside the nucleolus, as 
TERT was found to undergo a regulated translocation between the nucleoplasm and 
nucleolus [100]. The mPinXl localized inside the nucleoplasm might interact with 
the functioning telomerase and TRFl, as they are both located inside the 
nucleoplasm. 
mPinXlt possesses only the N-terminal, but not the C-terminal domain, of mPinXl. 
Since both mPinXl and mPinXlt localized mainly inside the nucleolus, this hints 
that the nucleolar signaling domain or structure resides in the N-terminal domain of 
mPinXl. In fact previous studies showed various contrasting results of the region in 
PinXl sequence on protein localization. In one study, hPinXl C-terminal deletion 
mutant inhibited the protein nucleolar localization (using an HA tag at N-terminus) 
[107], while in another study on hPinXl, deletion on N-terminal or C-terminal did 
not alter its nucleolar localization (using RFP tag at C-terminus) [54]. Deletion of 
N-terminus in rPinXl was found to inhibit its localization inside nucleolus (using HA 
tag at N-terminus) [68]. It is currently not clear that why many different results were 
found from other groups, but it is possible that the different location of tags might 
cause the difference. 
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4.5 mPinXl and mPinXlt interacted with mTERT 
PinXl was shown to bind to telomerase subunit TERT and inhibit telomerase 
activities in several species [54, 84, 112]. Both N-terminal and C-terminal ofhPinXl 
could interact with hTERT [16, 112]. Our data showed that mPinXl interacted with 
mTERT in vivo. mPinXlt, which lacked the C-terminal, also interacted with mTERT, 
indicating that the N-terminal alone of mPinXl is sufficient for its interaction with 
- i ‘ * 
mTERT. Previous studies on hPinXl showed that both the N-terminus and 
C-terminus ofhPinXl interact with hTERT, but only the C-terminus was found to be 
important for inhibiting telomerase activity. Moreover, there was no study showing 
how the interaction directly contributes to its negative regulation on telomerase 
activity. Thus, the function of this interaction between PinXl and TERT remains to 
be elucidated. 
4.6 Transient knockdown of mPinXl slightly inhibited, while over-expression 
of mPinXl slightly promoted telomerase activity 
Previous studies have shown that PinXl is a negative regulator of telomerase in 
cancer cells [93, 110，112] and normal somatic cells [84, 111]. In our experiments, 
transient knockdown of mPinXl in mESCs slightly inhibited telomerase activity 
(around 15%), while over-expression of mPinXl in mESCs slightly promoted 
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telomerase activity (around 10%). These results suggested that mPinXl may not act 
as a telomerase inhibitor in mESCs as in other cell lines; on the contrary, it promotes 
telomerase activity. 
There is so far no study showing the positive role of mPinXl on telomerase activity. 
Knock-down of mPinXl in mice increased the frequency of tumor formation; 
down-regulation of PinXl was found in many cancer cells [13, 58]. Its 
down-regulation might contribute to telomerase activation in cancer cells, but this 
mechanism might not be necessary in mESCs as mPinXl expression level is 
relatively high in mESCs (when compared to that of differentiated cells). Although 
both ESCs and cancer cells has a relatively high telomerase activity, PinXl expresses 
robustly in ESCs while its expression is downregulated/dysregulated in cancer cells. 
This difference in expression of mPinXl hints that the function of PinXl may be 
different in ESCs and cancer cells, the up-regulated telomerase activity caused by 
decreased expression of PinXl in cancer cells may not apply in ESCs. Besides, 
although mPinXl was found to interact with mTERT in our experiments, no study 
has been done on how this interaction directly contributes to its negative regulation 
on telomerase activity. It is also possible that mPinXl would affect telomerase 
activity, for example, by acting at the post-transcriptional level of mTERT transcript 
(as mPinXl contains a RNA binding G-patch), or by interacting with telomerase 
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associated proteins. PinXl was found to be an interacting partner of the telomeric 
protein TRFl. However, previous study showed that disrupting the interaction 
between PinXl and TRFl would not affect its telomerase regulation activity [82]. It 
is possible that mPinXl would have other interacting partners in mESCs which are at 
present unknown. These interactions might influence whether PinXl would act as an 
inhibitor or activator of telomerase activity. In the future, we could investigate this 
possibility by identifying the interacting partners of mPinXl in mESCs and 
comparing with that of cancer cells. 
In mESCs, a high level of telomerase activity is needed to maintain the self-renewal 
state by giving mESCs the ability to proliferate indefinitely with a stable telomere 
length [8, 56]. Besides, telomerase activity is crucial in differentiation processes [6] 
and stress resistance [48]. Studies have shown that the major mechanism of 
regulation of telomerase activity is the transcriptional regulation of the TERT gene 
[1]. In ESCs, there are many transcription factors, including the c-Myc, Hifl-a, Klf-4, 
SPl and STATS, which are robustly expressed to maintain the high level of 
expression of TERT [1, 22, 42, 94, 99, 101]. In this cellular context, the regulation of 
telomerase activity by mPinXl would be dispensable, so mPinXl might not be the 
rate-limiting physiological regulator of telomerase in mESCs, as shown by the minor 
change in telomerase activity caused by the alteration ofmPinXl expression. 
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In the future, another TRAP assay utilizing a gel based detection method by 
radioactive or non-radioactive means would be used to further confirm the change in 
telomerase activity we saw in these experiments [110]. Also, TRAP assay could be 
done on the differentiation derivatives of stable mPinXl over-expression and 
knockdown mESCs to compare the effect of mPinXl on telomerase in both 
undifferentiated mESCs and its differentiation derivatives. 
4.7 Both transient knockdown and over-expression of mPinXl inhibited the 
growth of mESCs 
Both cell cycle progression and pluripotency will affect the proliferation of mESCs. 
For the former one, if the gene promotes or inhibits transition of cell cycle phases, 
cell proliferation rate would be increased or decreased, respectively. Loss of 
pluripotency will cause the cells to leave the cell cycle and start differentiation, thus 
decreasing the rate of cell proliferation. However, our results showed that 
knockdown or over-expression of mPinXl did not affect both the cell cycle 
distribution and the pluripotency. It is possible that changing the expression of 
mPinXl affects some processes which do not specifically alter the transition of 
specific cell cycle phases, but lengthen each phase of the cell cycle; this could also 
lead to a decrease in cell proliferation. 
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Besides telomerase regulation, PinXl was found to be recruited in many cellular 
activities. PinXl was shown to involve in chromosome congression and segregation 
by binding to microtubules and nucleolin [50, 108]. On the other hand, PinXl was 
also found to be crucial for pre-ribosomal RNA processing and small nucleolar RNA 
maturation [36]. Knockdown of mPinXl might affect these cellular activities in 
addition to affecting the telomerase activity; this would result in a decrease in cell 
proliferation. 
Although many papers related the growth inhibition of over-expressing PinXl to its 
effect on inhibiting telomerase activity, the involvement of other related pathways 
causing crisis cannot be excluded. Over-expression of mPinXl might also affect 
other pathways which also contribute to growth inhibition. Moreover, PinXl was 
found to be recruited by TRFl to inhibit telomerase binding to telomere [82], so 
over-expression of mPinXl might increase the PinXl-TRFl complexes on telomere 
which prevent telomerase interacting with telomere. 
In the future, to investigate if there is telomerase-independent effect of mPinXl in 
mESCs, we can use TERT knockout cell lines to study the downstream effect of 
mPinXl on other cellular processes which might affect cell proliferation. 
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4.8 Both stable knockdown and over-expression of mPinXl did not affect cell 
proliferation and telomerase activity of mESCs 
Diverged from what we found in transient knockdown and over-expression 
experiments, both stable knockdown and over-expression did not exert significant 
effect on cell proliferation and telomerase activity. It was quite surprising because we 
anticipated that the effect in transient experiments could be magnified in stable cell 
lines. Throughout the experiment, GFP signals from all groups were observed under 
fluorescence microscope frequently to make sure that the genes/ shRNA were 
robustly expressing. As discussed before, there are many other pathways in mESCs 
regulating telomerase activity, mPinXl might not be the rate-limiting physiological 
regulator of telomerase and so its effect on telomerase activity would be very minor. 
These telomerase regulating pathways might co-ordinate in a way that the slight 
changes in telomerase activity caused by the alteration in mPinXl expression would 
be diminished for the cell to come back to the original homeostatic state; this can 
explain why cell proliferation was not affected as well. These compensatory 
mechanisms might need a longer time to respond to the change, so the effect could be 
seen in transient experiments but not in stable cell lines. 
( 
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4.9 Involvement of mPinXl and mPinXlt in the differentiation process of 
mESCs 
From the qPCR results showing the significant decrease of expression of mPinXl 
during differentiation, it is very possible that its main function is on the 
differentiation process. Preliminary results of differentiation of the stable cell lines 
showed that over-expression or knockdown of mPinXl did not lead to a significant 
change in the size of EBs formed at day 7. However, over-expression of mPinXl 
advanced the time of reaching maximum percentage of beating EBs, while 
knockdown of mPinXl decreased the percentage of beating EBs formed. These 
results suggested that mPinXl is essential for cardiac differentiation. However, it is 
at present indistinguishable whether the effect of mPinXl is on general mesodermal 
differentiation, or specifically on cardiogenic differentiation. Besides, as the size of 
the beating EBs could vary a lot, the percentage of cardiomyocytes present in the 
population could not be fully reflected by the number of beating clusters. Therefore, 
in the future, quantitative measurement of the expression of 1) three germ layer 
makers (e.g. ectoderm: Soxl; mesoderm: Mixll, Brachyury T, Nodal; endoderm: 
HNF-IP) on early differentiation days; 2) cardiac specific transcription factors (e.g. 
GATA-4 and Nkx2.5) on early differentiation days; and 3) cardiac structural protein 
genes (e.g. Mlc2a, Mlc2v, cardiac actin, a-MHC, troponin T) on late differentiation 
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days would be done to evaluate the mechanism behind. In addition, more 
independent experiments (n numbers) have to be conducted to obtain more 
convincing data. 
Up to date, no study has been conducted about the effect of PinXl on the ESC 
differentiation process, but a recent paper showed that total knockout of PinXl is 
embryonic lethal, while some of the PinXl heterozygous embryos died in utero, 
indicating PinXl is essential for embryonic development [111]. Besides, it was found 
that over-expressing telomerase activity in murine ESCs enhanced differentiation 
towards the hematopoietic lineage [6]. In fact, enhanced hematopoietic 
differentiation was found to impair cardiac differentiation and vice versa. For 
example, ESCs with Wnt2" '^ was found to have impaired terminal cardiac 
differentiation, but enhanced hematopoietic cell differentiation [92]. Also Wnt-1 
over-expression enforced cardiac differentiation, but inhibited hematopoietic cell 
differentiation in ESCs [97]. Taken together, mPinXl is involved in the 
differentiation process, and it is possible that mPinXl would regulate telomerase 
activity during differentiation of ESCs, thereby affecting the differentiation pattern in 
mesoderm layer. ‘ 
Therefore, in the future, quantitative measurement on the genes of other lineages, 
including the hematopoietic lineage, will be done to see if mPinXl would also affect 
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the differentiation of other lineages. TRAP assay could be done to investigate if 
mPinXl would affect telomerase activity during differentiation. 
Over-expression of mPinXlt caused a slight delay of the onset of spontaneous 
beating in EBs. From qPCR data, its expression decreased during differentiation, in a 
way opposite to the expression pattern of mPinXl. It is possible that over-expression 
of mPinXlt would exert a different effect on differentiation when compared with the 
effect seen with over-expressing mPinXl. The experiment would need to be repeated 
in the future to get more convincing data. 
4.10 Regulation of mPinXl gene expression by mPinXlt 
In both transient and stable over-expression of mPinXlt, the expression of mPinXl 
gene was elevated. However, over-expression of mPinXl did not alter the expression 
of mPinXlt. This hints that mPinXlt might be involved in positively regulating the 
level of mPinXl. mPinXlt gene consists of the N-terminal of mPinXl, which 
contains a G-patch region that could bind RNA, together with the additional peptide 
sequence (which is present in mPinXlt but not mPinXl), mPinXlt might bind to the 
mRNA of mPinXl and post-transcriptionally regulate it. Although mPinXl protein 
also possesses the same N-terminal G-patch region, the secondary structure of the 
C-terminus of mPinXl might mask its own G-patch region, thus only mPinXlt 
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protein (which does not contain the C-terminus of mPinXl) could bind to the 
mPinXl mRNA and regulate it while mPinXl protein could not. Many genes were 
shown to be regulated by their own splice variants [47, 65]. Over-expression of 
mPinXlt did not affect telomerase activity, cell cycle progression and pluripotency, 
suggesting that it is also not involved in these cellular processes. The decrease in cell 
proliferation in transient over-expression of mPinXlt might due to the effect of 
increased mPinXl expression. 
It would be more convincing if we can see the opposite effect with the knockdown of 
mPinXlt, however, the siRNAs against mPinXlt failed to work with unknown 
reasons. In the future, we could investigate whether mPinXlt would bind to mPinXl 
mRNA to regulate mPinXl gene expression. 
4.11 Future perspectives 
In the present study, the role of mPinXl on telomerase activity and other cellular 
processes in mESCs were investigated. It was found that mPinXl slightly promoted 
telomerase activity in mESCs in transient knockdown and over-expression 
experiments but not in stable cell lines. It would be more convincing to detect the 
telomerase activity again using another TRAP assay in these experiments. Both 
transient over-expression and knockdown of gene was found to inhibit proliferation. 
� 152 
) 
Chapter 4 Discussions 
It would be interesting to know the other pathways that mPinXl would be involved 
in for cell proliferation. Therefore, TERT knockout mESCs cell lines would be used 
in the future to study the functions of mPinXl. In long term over-expression and 
knockdown of mPinXl and mPinXlt, more independent experiments would be 
added to the cell cycle analysis and western blot analysis on pluripotent markers. 
Results also showed that mPinXl would affect the differentiation pattern of mESCs. 
Whether this effect is caused by alteration in telomerase activity by mPinXl during 
differentiation, and whether the differentiation lineages would be affected by 
mPinXl, would be studied in the future by quantitative measurements of the 
respective genes involved and TRAP assay. More n will also be added to make the 
data more convincing. 
Besides, many puzzles about the function of the splice variant mPinXlt are awaited 
to be solved. The presence of the full transcript of mPinXlt in mESCs would be 
confirmed by northern blot analysis. Its function on mPinXl gene regulation would 
be investigated in the future by looking at its interaction with mPinXl mRNA. In 
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CHAPTER FIVE CONCLUSION 
In summary, a telomerase regulator mPinXl and its novel splice variant mPinXlt 
were characterized and their roles in maintaining mESCs characteristics were studied. 
Both mPinXl and mPinXlt were found to be present in all investigated mouse 
tissues, undifferentiated mESCs and their Day 7+25 differentiation derivatives. The 
expression of mPinXl was down-regulated upon differentiation while for mPinXlt 
the expression pattern was opposite. Both of them were found to be pre-dominantly 
localized in the nucleolus of mESCs, and they were found to interact with mTERT in 
vivo. 
To study their roles in maintaining mESCs characteristics, transient knockdown of 
mPinXl, and over-expression of mPinXl and mPinXlt were done in mESCs. 
mPinXl knockdown slightly decreased telomerase activity, while over-expression 
slightly increased telomerase activity, suggesting that PinXl did not act as a 
telomerase inhibitor in mESCs at cellular level. Both transient knockdown and 
over-expression of mPinXl caused an inhibitory effect on cell proliferation without 
affecting cell cycle distribution and pluripotency. Over-expression of mPinXlt 
up-regulated mPinXl mRNA expression, suggesting its regulatory role on mPinXl 
gene expression. Transient over-expression of mPinXlt also caused an inhibitory 
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effect on cell proliferation without affecting cell cycle distribution and pluripotency, 
which might be due to the effect of increased mPinXl expression. Further 
experiments are needed to verify its role on mPinXl regulation. 
Diverged from the results of transient experiments, stable knockdown and 
over-expression of mPinXl did not cause any significant effect on cell proliferation 
and telomerase activity. These stable cell lines were subjected to differentiation. 
Preliminary results showed that the size of EBs formed from all groups had no 
difference at Day 7. On the other hand, mPinXl over-expressed groups caused an 
advanced onset of time in reaching maximum beating EBs, while mPinXl 
knockdown groups caused a decreased percentage of beating EBs formed. 
Over-expression of mPinXlt also caused a slight delay of onset of spontaneous 
beating EBs, suggesting a possible role of mPinXl and mPinXlt in mESCs 
differentiation. 
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